RxNorm Semantic Concepts Index - 148
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "148".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 1480 | Beta-galactosidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1480 | Beta-galactosidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1480 | Beta-galactosidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1480 | Beta-galactosidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1482 | Amygdalase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482 | Amygdalase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1482 | Amygdalase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1482 | Amygdalase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482 | Amygdalase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482501 | eslicarbazepine acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1482501 | eslicarbazepine acetate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482501 | eslicarbazepine acetate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482502 | eslicarbazepine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1482502 | eslicarbazepine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482502 | eslicarbazepine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482502 | eslicarbazepine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482502 | eslicarbazepine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482503 | eslicarbazepine acetate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1482504 | eslicarbazepine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1482504 | eslicarbazepine Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482504 | eslicarbazepine Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482505 | eslicarbazepine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1482506 | eslicarbazepine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1482507 | eslicarbazepine acetate 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482507 | eslicarbazepine acetate 200 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482507 | eslicarbazepine acetate 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1482507 | eslicarbazepine acetate 200 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482508 | Aptiom | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1482509 | eslicarbazepine acetate 200 MG [Aptiom] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1482510 | eslicarbazepine Oral Tablet [Aptiom] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482511 | Aptiom Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1482512 | Aptiom Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1482513 | Aptiom 200 MG Oral Tablet, Once Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482513 | Aptiom 200 MG Oral Tablet, Once Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482513 | Aptiom 200 MG Oral Tablet, Once Daily | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482514 | eslicarbazepine acetate 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1482515 | eslicarbazepine acetate 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482515 | eslicarbazepine acetate 400 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482515 | eslicarbazepine acetate 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1482515 | eslicarbazepine acetate 400 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482516 | eslicarbazepine acetate 400 MG [Aptiom] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1482517 | Aptiom 400 MG Oral Tablet, Once Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482517 | Aptiom 400 MG Oral Tablet, Once Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482517 | Aptiom 400 MG Oral Tablet, Once Daily | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482520 | eslicarbazepine acetate 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1482521 | eslicarbazepine acetate 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482521 | eslicarbazepine acetate 600 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482521 | eslicarbazepine acetate 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1482521 | eslicarbazepine acetate 600 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482522 | eslicarbazepine acetate 600 MG [Aptiom] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1482523 | Aptiom 600 MG Oral Tablet, Once Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482523 | Aptiom 600 MG Oral Tablet, Once Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482523 | Aptiom 600 MG Oral Tablet, Once Daily | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482524 | eslicarbazepine acetate 800 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1482525 | eslicarbazepine acetate 800 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482525 | eslicarbazepine acetate 800 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482525 | eslicarbazepine acetate 800 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1482525 | eslicarbazepine acetate 800 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482526 | eslicarbazepine acetate 800 MG [Aptiom] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1482527 | Aptiom 800 MG Oral Tablet, Once Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482527 | Aptiom 800 MG Oral Tablet, Once Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482527 | Aptiom 800 MG Oral Tablet, Once Daily | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482528 | Wal Zyr 24 Hour Allergy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1482529 | cetirizine hydrochloride 1 MG/ML [Wal Zyr 24 Hour Allergy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1482530 | cetirizine Oral Solution [Wal Zyr 24 Hour Allergy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482531 | Wal Zyr 24 Hour Allergy Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1482532 | Wal Zyr 24 Hour Allergy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1482533 | Wal-Zyr Children's 5 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482533 | Wal-Zyr Children's 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482533 | Wal-Zyr Children's 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482533 | Wal-Zyr Children's 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482533 | Wal-Zyr Children's 5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482534 | 2,5-diaminotoluene sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1482535 | 2,5-diaminotoluene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482536 | Eryngium maritimum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482537 | Malus domestica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1482538 | acai fruit pulp | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482539 | Oil of parsley | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1482539 | Oil of parsley | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1482539 | Oil of parsley | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482540 | PPG-30 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482541 | Argania spinosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1482542 | Celosia argentea seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482543 | Levisticum officinale root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482544 | Polygonum punctatum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482544 | Polygonum punctatum extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482545 | Pteridium aquilinum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482546 | Rickettsia rickettsii | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482547 | Asplenium scolopendrium top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482548 | Prunus spinosa fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1482549 | bovine brainstem preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482549 | bovine brainstem preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482550 | wheat sprout extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482551 | 9,10-anthraquinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482551 | 9,10-anthraquinone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1482551 | 9,10-anthraquinone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1482583 | tolnaftate Topical Cream [Proclearz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482584 | Proclearz 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482584 | Proclearz 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482584 | Proclearz 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482584 | Proclearz 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482612 | menthol 78 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1482613 | menthol 7.8 % / methyl salicylate 3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482613 | menthol 7.8 % / methyl salicylate 3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482613 | menthol 7.8 % / methyl salicylate 3 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1482614 | Max Revive | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1482615 | menthol 78 MG/ML / methyl salicylate 30 MG/ML [Max Revive] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1482616 | menthol / methyl salicylate Topical Spray [Max Revive] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482617 | Max Revive Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1482618 | Max Revive 7.8 % / 3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482618 | Max Revive 7.8 % / 3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482618 | Max Revive 7.8 % / 3 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482626 | menthol 1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482626 | menthol 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482626 | menthol 1 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1482627 | Ivarest Medicated Poison Ivy Cleansing Foam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1482628 | menthol 10 MG/ML [Ivarest Medicated Poison Ivy Cleansing Foam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1482629 | menthol Medicated Liquid Soap [Ivarest Medicated Poison Ivy Cleansing Foam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482630 | Ivarest Medicated Poison Ivy Cleansing Foam Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1482631 | IVAREST Medicated Poison Ivy Cleansing Foam 1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482631 | IVAREST Medicated Poison Ivy Cleansing Foam 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482631 | IVAREST Medicated Poison Ivy Cleansing Foam 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482631 | IVAREST Medicated Poison Ivy Cleansing Foam 1 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482632 | ammonium thioglycolate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1482633 | arginine pyroglutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482634 | Ornithine monoxoglurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482634 | Ornithine monoxoglurate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482634 | Ornithine monoxoglurate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1482634 | Ornithine monoxoglurate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1482634 | Ornithine monoxoglurate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482641 | benzoyl peroxide 10 % Topical Cream (13 GM) / salicylic acid 2 % Medicated Liquid Soap (150 ML) / salicylic acid 0.5 % Topical Lotion (45 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1482641 | benzoyl peroxide 10 % Topical Cream (13 GM) / salicylic acid 2 % Medicated Liquid Soap (150 ML) / salicylic acid 0.5 % Topical Lotion (45 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482644 | chlorhexidine gluconate 23 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1482645 | chlorhexidine / ketoconazole Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1482646 | chlorhexidine gluconate 2.3 % / detoconazole 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482646 | chlorhexidine gluconate 2.3 % / detoconazole 1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1482652 | Resi Ketochlor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1482653 | chlorhexidine gluconate 23 MG/ML / ketoconazole 10 MG/ML [Resi Ketochlor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1482654 | chlorhexidine / ketoconazole Topical Lotion [Resi Ketochlor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482655 | Resi Ketochlor Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1482656 | Resi Ketochlor (chlorhexidine gluconate 2.3 % / ketoconazole 1 % ) Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482656 | Resi Ketochlor (chlorhexidine gluconate 2.3 % / ketoconazole 1 % ) Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482656 | Resi Ketochlor (chlorhexidine gluconate 2.3 % / ketoconazole 1 % ) Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482657 | chlorhexidine gluconate 2.3 % / ketoconazole 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482657 | chlorhexidine gluconate 2.3 % / ketoconazole 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482657 | chlorhexidine gluconate 2.3 % / ketoconazole 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1482658 | Ketochlor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1482659 | chlorhexidine gluconate 23 MG/ML / ketoconazole 10 MG/ML [Ketochlor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1482660 | chlorhexidine / ketoconazole Medicated Shampoo [Ketochlor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482662 | KetoChlor 2.3 % / 1 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482662 | KetoChlor 2.3 % / 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482662 | KetoChlor 2.3 % / 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482670 | Ostilox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1482671 | meloxicam 5 MG/ML [Ostilox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1482672 | meloxicam Injectable Solution [Ostilox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482673 | Ostilox Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1482674 | meloxicam 5 MG/ML Injectable Solution [Ostilox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482674 | meloxicam 5 MG/ML Injectable Solution [Ostilox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482675 | Diaderm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1482676 | undecylenic acid 100 MG/ML [Diaderm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1482677 | undecylenate Topical Cream [Diaderm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482678 | Diaderm Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1482679 | Diaderm 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482679 | Diaderm 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482679 | Diaderm 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482679 | Diaderm 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482680 | luliconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1482680 | luliconazole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482680 | luliconazole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482680 | luliconazole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482680 | luliconazole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482681 | luliconazole 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1482682 | luliconazole Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1482682 | luliconazole Topical Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482682 | luliconazole Topical Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482683 | luliconazole Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1482684 | luliconazole 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482684 | luliconazole 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482684 | luliconazole 1 % Topical Cream | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482684 | luliconazole 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1482684 | luliconazole 1 % Topical Cream | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482685 | Luzu | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1482686 | luliconazole 10 MG/ML [Luzu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1482687 | luliconazole Topical Cream [Luzu] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482688 | Luzu Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1482689 | Luzu 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482689 | Luzu 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482689 | Luzu 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482689 | Luzu 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482690 | Ketochlor Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1482786 | PPG-2 hydroxyethyl stearamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482787 | Hyssopus officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482788 | Cistus incanus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482789 | Cordia sebestena flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482790 | simeprevir | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1482790 | simeprevir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482790 | simeprevir | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1482790 | simeprevir | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1482790 | simeprevir | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1482791 | Dactylopius coccus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482792 | penoxsulam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482793 | Tylophora indica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482794 | Curcuma aromatica root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482795 | magnesium phosphate, dibasic | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1482797 | simeprevir 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1482798 | simeprevir Oral Product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1482798 | simeprevir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1482798 | simeprevir Oral Product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1482799 | simeprevir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1482800 | simeprevir Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1482801 | simeprevir 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482801 | simeprevir 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1482802 | Olysio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1482803 | simeprevir 150 MG [Olysio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1482804 | simeprevir Oral Capsule [Olysio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482805 | Olysio Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1482806 | Olysio Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1482807 | Olysio 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482807 | Olysio 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482807 | Olysio 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482807 | Olysio 150 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482808 | coal tar 0.02 MG/MG [Elta Plus Tar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1482809 | coal tar Topical Ointment [Elta Plus Tar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482810 | elta plus tar 2 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482810 | elta plus tar 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482810 | elta plus tar 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482810 | elta plus tar 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482811 | toceranib phosphate 50 MG [Palladia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1482812 | Palladia 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482812 | Palladia 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482812 | Palladia 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482813 | golimumab 100 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1482813 | golimumab 100 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482813 | golimumab 100 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482814 | Simponi 100 MG in 1 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482814 | Simponi 100 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482814 | Simponi 100 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482814 | Simponi 100 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482815 | dextromethorphan HBr 5 MG / guaiFENesin 75 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1482815 | dextromethorphan HBr 5 MG / guaiFENesin 75 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1482815 | dextromethorphan HBr 5 MG / guaiFENesin 75 MG in 5 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1482815 | dextromethorphan HBr 5 MG / guaiFENesin 75 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482815 | dextromethorphan HBr 5 MG / guaiFENesin 75 MG in 5 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1482816 | gabapentin enacarbil 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1482818 | gabapentin enacarbil 300 MG [Horizant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1482820 | gabapentin enacarbil 300 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482820 | gabapentin enacarbil 300 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1482821 | Horizant 300 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482821 | Horizant 300 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482821 | Horizant 300 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482905 | posaconazole 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1482906 | posaconazole Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1482907 | posaconazole Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1482908 | posaconazole 100 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482908 | posaconazole 100 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1482908 | posaconazole 100 MG Delayed Release Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1482908 | posaconazole 100 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1482909 | posaconazole 100 MG [Noxafil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1482910 | posaconazole Delayed Release Oral Tablet [Noxafil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482911 | Noxafil Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1482912 | Noxafil 100 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1482912 | Noxafil 100 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1482912 | Noxafil 100 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1482913 | technetium (99mTc) sestamibi | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1482913 | technetium (99mTc) sestamibi | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1482913 | technetium (99mTc) sestamibi | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1482913 | technetium (99mTc) sestamibi | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1482914 | hydroxypropylcocoate PEG-8 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1482991 | Brace Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1482993 | benzocaine Oral Gel [Brace Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1482994 | Brace Relief Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1482995 | Brace Relief Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1483080 | sorbityl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483137 | Mederma Stretch Mark Therapy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1483138 | dimethicone 20 MG/ML [Mederma Stretch Mark Therapy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1483139 | dimethicone Topical Cream [Mederma Stretch Mark Therapy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483140 | Mederma Stretch Mark Therapy Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1483141 | Mederma Stretch Mark Therapy 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483141 | Mederma Stretch Mark Therapy 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483141 | Mederma Stretch Mark Therapy 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483141 | Mederma Stretch Mark Therapy 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483143 | glycerin 20 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483143 | glycerin 20 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483143 | glycerin 20 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483179 | Clearasil Daily Clear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1483180 | salicylic acid 20 MG/ML [Clearasil Daily Clear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483181 | salicylic acid Medicated Pad [Clearasil Daily Clear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483182 | Clearasil Daily Clear Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1483183 | Clearasil Daily Clear Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1483184 | Clearasil Daily Clear 2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483184 | Clearasil Daily Clear 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483184 | Clearasil Daily Clear 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483184 | Clearasil Daily Clear 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483184 | Clearasil Daily Clear 2 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483189 | salicylic acid Topical Lotion [Clearasil Daily Clear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483190 | Clearasil Daily Clear Hydra-Blast 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483190 | Clearasil Daily Clear Hydra-Blast 2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483190 | Clearasil Daily Clear Hydra-Blast 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483190 | Clearasil Daily Clear Hydra-Blast 2 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483191 | benzalkonium / benzocaine / menthol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1483192 | benzalkonium / benzocaine / menthol Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1483193 | benzalkonium / benzocaine / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1483194 | benzalkonium chloride 0.1 % / benzocaine 20 % / menthol 0.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483194 | benzalkonium chloride 0.1 % / benzocaine 20 % / menthol 0.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483207 | ethanol 0.4 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483208 | chloroxylenol / ethanol Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1483209 | chloroxylenol / ethanol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1483210 | chloroxylenol / ethanol Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1483211 | chloroxylenol / ethanol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1483212 | chloroxylenol 0.5 % / ethanol 40 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483212 | chloroxylenol 0.5 % / ethanol 40 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483212 | chloroxylenol 0.5 % / ethanol 40 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483214 | Dermacool HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1483215 | hydrocortisone 10 MG/ML [Dermacool HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483216 | hydrocortisone Topical Spray [Dermacool HC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483217 | Dermacool HC Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1483218 | DERMACOOL HC 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483218 | DERMACOOL HC 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483218 | DERMACOOL HC 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483218 | DERMACOOL HC 1 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483219 | Resicort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1483220 | hydrocortisone 10 MG/ML [Resicort] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483221 | hydrocortisone Topical Lotion [Resicort] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483222 | Resicort Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1483223 | Resicort 1 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483223 | Resicort 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483223 | Resicort 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483223 | Resicort 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483223 | Resicort 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483224 | benzalkonium chloride 0.1 % / benzocaine 20 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483224 | benzalkonium chloride 0.1 % / benzocaine 20 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483230 | hydrogenated jojoba oil-jojoba oil, randomized (iodine value 57-61) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1483231 | karum seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483232 | octyldodecyl oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483250 | deslorelin acetate 1.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483251 | deslorelin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1483252 | deslorelin Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1483253 | deslorelin acetate 1.8 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483254 | SucroMate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1483255 | deslorelin acetate 1.8 MG/ML [SucroMate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483256 | deslorelin Injectable Suspension [SucroMate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483257 | SucroMate Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1483258 | deslorelin acetate 1.8 MG/ML Injectable Suspension [SucroMate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483258 | deslorelin acetate 1.8 MG/ML Injectable Suspension [SucroMate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483262 | spermidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1483263 | spermine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1483264 | strychnine phosphate dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1483265 | camphor 10 % / menthol 36 % / methyl salicylate 40 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483265 | camphor 10 % / menthol 36 % / methyl salicylate 40 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483265 | camphor 10 % / menthol 36 % / methyl salicylate 40 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483267 | raw sugar | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483316 | hypochlorous acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1483316 | hypochlorous acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1483316 | hypochlorous acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1483317 | hypochlorite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483318 | RABEprazole sodium 10 MG Delayed Release Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483318 | RABEprazole sodium 10 MG Delayed Release Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483318 | RABEprazole sodium 10 MG Delayed Release Oral Granules | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483318 | RABEprazole sodium 10 MG Delayed Release Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1483318 | RABEprazole sodium 10 MG Delayed Release Oral Granules | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483319 | Aciphex 10 MG Delayed Release Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483319 | Aciphex 10 MG Delayed Release Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483319 | Aciphex 10 MG Delayed Release Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483319 | Aciphex 10 MG Delayed Release Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483319 | Aciphex 10 MG Delayed Release Oral Granules | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483320 | hypochlorous acid 0.02 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483321 | hypochlorite Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1483322 | hypochlorite Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1483323 | hypochlorous acid 0.002 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483323 | hypochlorous acid 0.002 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483323 | hypochlorous acid 0.002 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483324 | VeteriBac | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1483325 | hypochlorous acid 0.02 MG/ML [VeteriBac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483326 | hypochlorite Topical Solution [VeteriBac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483327 | VeteriBac Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1483328 | VeteriBac 0.002 % Pets Antiseptic Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483328 | VeteriBac 0.002 % Pets Antiseptic Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483328 | VeteriBac 0.002 % Pets Antiseptic Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483328 | VeteriBac 0.002 % Pets Antiseptic Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483329 | TENCON Tablets 50 MG / 325 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483329 | TENCON Tablets 50 MG / 325 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483329 | TENCON Tablets 50 MG / 325 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483329 | TENCON Tablets 50 MG / 325 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483330 | Flulaval Quad 2013-2014 Formula | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1483331 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval Quad 2013-2014 Formula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483332 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Flulaval Quad 2013-2014 Formula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483333 | Flulaval Quad 2013-2014 Formula Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1483334 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval Quad 2013-2014 Formula] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483334 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval Quad 2013-2014 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483339 | potassium chloride 20 MEQ [K-Tab] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1483340 | K-Tab 20 MEQ (1500 MG) Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483340 | K-Tab 20 MEQ (1500 MG) Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483340 | K-Tab 20 MEQ (1500 MG) Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483340 | K-Tab 20 MEQ (1500 MG) Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483340 | K-Tab 20 MEQ (1500 MG) Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483340 | K-Tab 20 MEQ (1500 MG) Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483341 | thymol 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483342 | thymol Soap Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1483343 | thymol Medicated Liquid Soap | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1483344 | thymol 0.15 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483344 | thymol 0.15 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483344 | thymol 0.15 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483413 | iodine 5 MG/ML [UdderBlend] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483414 | UdderBlend EFC 5, 0.5 % Iodine Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483414 | UdderBlend EFC 5, 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483414 | UdderBlend EFC 5, 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483414 | UdderBlend EFC 5, 0.5 % Iodine Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483422 | cucumber seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483423 | Eucalyptus radiata leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483424 | Cupressus sempervirens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1483425 | Lavandula dentata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1483546 | Drospirenone- and estradiol-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1483546 | Drospirenone- and estradiol-containing product in oral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1483546 | Drospirenone- and estradiol-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1483547 | drospirenone / estradiol Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1483548 | drospirenone / estradiol Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1483549 | drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483549 | drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1483550 | Drospiren-Estra 0.25-0.5 (28) Oral Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1483550 | Drospiren-Estra 0.25-0.5 (28) Oral Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483551 | Angeliq 0.25/0.5 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1483551 | Angeliq 0.25/0.5 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483551 | Angeliq 0.25/0.5 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483552 | drospirenone 0.5 MG / estradiol 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483552 | drospirenone 0.5 MG / estradiol 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1483553 | Drospiren-Eth estra 0.5-1 MG (28) Oral Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1483553 | Drospiren-Eth estra 0.5-1 MG (28) Oral Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483553 | Drospiren-Eth estra 0.5-1 MG (28) Oral Tablet 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483554 | Angeliq 0.5/1 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1483554 | Angeliq 0.5/1 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483554 | Angeliq 0.5/1 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483555 | ferrous fumarate 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483556 | ferrous fumarate 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483556 | ferrous fumarate 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483558 | Zenchent Fe 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1483558 | Zenchent Fe 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483558 | Zenchent Fe 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483558 | Zenchent Fe 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483567 | docusate sodium 100 MG [DOK] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1483568 | docusate Oral Capsule [DOK] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483569 | DOK Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1483570 | DOK Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1483571 | DOK 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483571 | DOK 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483571 | DOK 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483571 | DOK 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483573 | docusate Oral Tablet [DOK] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483574 | DOK 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483574 | DOK 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483574 | DOK 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483574 | DOK 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483575 | inosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1483614 | diphenhydramine hydrochloride 12.5 MG [Wal-Dryl Allergy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1483614 | diphenhydramine hydrochloride 12.5 MG [Wal-Dryl Allergy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483615 | diphenhydrAMINE Disintegrating Oral Tablet [Wal-Dryl Allergy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483615 | diphenhydrAMINE Disintegrating Oral Tablet [Wal-Dryl Allergy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483616 | Wal-Dryl Allergy Disintegrating Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1483617 | Wal-Dryl Children's Allergy 12.5 MG Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483617 | Wal-Dryl Children's Allergy 12.5 MG Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483617 | Wal-Dryl Children's Allergy 12.5 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483617 | Wal-Dryl Children's Allergy 12.5 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483618 | sodium hydride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483620 | Rosa rugosa flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483623 | hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG [Uretron DS] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483624 | Uretron D-S 0.12 MG / 120 MG / 10.8 MG / 36.2 MG / 40.8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483624 | Uretron D-S 0.12 MG / 120 MG / 10.8 MG / 36.2 MG / 40.8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483624 | Uretron D-S 0.12 MG / 120 MG / 10.8 MG / 36.2 MG / 40.8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483628 | salicylic acid 167 MG/ML [Gordofilm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1483629 | Gordofilm 16.7 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483629 | Gordofilm 16.7 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483629 | Gordofilm 16.7 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483629 | Gordofilm 16.7 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483664 | ethanol 0.554 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483665 | ethanol 55.4 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483665 | ethanol 55.4 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483665 | ethanol 55.4 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483671 | sodium fluoride 0.0014 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483673 | sodium fluoride 0.14 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483673 | sodium fluoride 0.14 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483673 | sodium fluoride 0.14 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483676 | zolmitriptan 2.5 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1483676 | zolmitriptan 2.5 MG/ACTUAT | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483677 | ZOLMitriptan 2.5 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483677 | ZOLMitriptan 2.5 MG/ACTUAT Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483677 | ZOLMitriptan 2.5 MG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483677 | ZOLMitriptan 2.5 MG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1483677 | ZOLMitriptan 2.5 MG/ACTUAT Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483678 | zolmitriptan 2.5 MG/ACTUAT [Zomig] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1483678 | zolmitriptan 2.5 MG/ACTUAT [Zomig] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483679 | Zomig 2.5 MG/ACTUAT Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483679 | Zomig 2.5 MG/ACTUAT Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1483679 | Zomig 2.5 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483679 | Zomig 2.5 MG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483681 | lutein 45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483682 | zeaxanthin 1.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483683 | lutein 45 MG / zeaxanthin 1.8 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483683 | lutein 45 MG / zeaxanthin 1.8 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483688 | menthol 5 % / methyl salicylate 1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483688 | menthol 5 % / methyl salicylate 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483688 | menthol 5 % / methyl salicylate 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483690 | disodium (ethoxycarbonyl)phosphonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1483722 | dextromethorphan hydrobromide 1.5 MG/ML [Babee Cof] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1483723 | Babee Cof 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483723 | Babee Cof 7.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483723 | Babee Cof 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483723 | Babee Cof 7.5 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483725 | dextromethorphan hydrobromide 1.5 MG/ML [Elixsure Cough] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1483726 | Elixsure Cough DM 7.5 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483726 | Elixsure Cough DM 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483726 | Elixsure Cough DM 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483726 | Elixsure Cough DM 7.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483727 | sodium Na-22 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1483728 | amodimethicone (3500 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483729 | Asparagus adscendens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1483733 | dextromethorphan hydrobromide 1.5 MG/ML [St. Joseph Cough Suppressant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483734 | St. Joseph Cough Suppressant 7.5 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483734 | St. Joseph Cough Suppressant 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483734 | St. Joseph Cough Suppressant 7.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483734 | St. Joseph Cough Suppressant 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483735 | C11-15 pareth-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1483736 | glycereth-5 lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1483741 | dextromethorphan hydrobromide 1.5 MG/ML [Benylin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483742 | Benylin Pediatric 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483742 | Benylin Pediatric 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483742 | Benylin Pediatric 7.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483742 | Benylin Pediatric 7.5 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483743 | naltrexone hydrochloride 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1483744 | naltrexone HCl 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483744 | naltrexone HCl 50 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1483744 | naltrexone HCl 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1483744 | naltrexone HCl 50 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1483745 | naltrexone hydrochloride 50 MG [ReVia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1483746 | ReVia 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1483746 | ReVia 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1483746 | ReVia 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1483766 | naltrexone hydrochloride 50 MG [Depade] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483767 | Depade 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483767 | Depade 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483767 | Depade 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483768 | PROcure Psoriapalm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1483769 | salicylic acid 20 MG/ML [PROcure Psoriapalm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483770 | salicylic acid Topical Lotion [PROcure Psoriapalm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483771 | PROcure Psoriapalm Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1483772 | PROcure Psoriapalm 20 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483772 | PROcure Psoriapalm 20 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483772 | PROcure Psoriapalm 20 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483772 | PROcure Psoriapalm 20 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483773 | naltrexone hydrochloride 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483774 | naltrexone HCl 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483774 | naltrexone HCl 100 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1483774 | naltrexone HCl 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483774 | naltrexone HCl 100 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1483775 | naltrexone hydrochloride 100 MG [Depade] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483776 | naltrexone hydrochloride 100 MG Oral Tablet [Depade] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483776 | naltrexone hydrochloride 100 MG Oral Tablet [Depade] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483777 | acetamidopropyl trimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1483778 | acetamidopropyl trimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1483779 | naltrexone hydrochloride 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1483780 | naltrexone HCl 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483780 | naltrexone HCl 25 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1483780 | naltrexone HCl 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1483780 | naltrexone HCl 25 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1483781 | naltrexone hydrochloride 25 MG [Depade] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483782 | naltrexone hydrochloride 25 MG Oral Tablet [Depade] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483782 | naltrexone hydrochloride 25 MG Oral Tablet [Depade] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483793 | atorvastatin calcium propylene glycol solvate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1483794 | SkinTx Acne Treatment | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1483795 | benzoyl peroxide 50 MG/ML [SkinTx Acne Treatment] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1483796 | benzoyl peroxide Topical Lotion [SkinTx Acne Treatment] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483797 | SkinTx Acne Treatment Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1483798 | SkinTx Acne Treatment 5 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1483798 | SkinTx Acne Treatment 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1483798 | SkinTx Acne Treatment 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483798 | SkinTx Acne Treatment 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1483807 | ethyl linolenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484080 | 5 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484081 | 5 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484081 | 5 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484081 | 5 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484081 | 5 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484082 | 7 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484083 | 7 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484083 | 7 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484083 | 7 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484083 | 7 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484084 | 14 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484085 | 14 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484085 | 14 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484085 | 14 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484085 | 14 ACTUAT follitropin alfa 75 UNT/ACTUAT Prefilled Syringe [Gonal F] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484086 | hydroxyzine pamoate 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1484086 | hydroxyzine pamoate 5 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1484087 | hydroxyzine pamoate 5 MG/ML [Vistaril] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484087 | hydroxyzine pamoate 5 MG/ML [Vistaril] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1484088 | hydroxyzine pamoate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1484088 | hydroxyzine pamoate 50 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1484089 | hydroxyzine pamoate 50 MG [Hypam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484089 | hydroxyzine pamoate 50 MG [Hypam] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1484090 | hydroxyzine pamoate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1484090 | hydroxyzine pamoate 25 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1484091 | hydroxyzine pamoate 25 MG [Hypam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484091 | hydroxyzine pamoate 25 MG [Hypam] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1484092 | hydroxyzine pamoate 50 MG [Vistaril] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1484092 | hydroxyzine pamoate 50 MG [Vistaril] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1484093 | hydroxyzine pamoate 25 MG [Vistaril] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1484093 | hydroxyzine pamoate 25 MG [Vistaril] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1484094 | hydroxyzine pamoate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1484094 | hydroxyzine pamoate 100 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1484095 | hydroxyzine pamoate 100 MG [Vistaril] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484095 | hydroxyzine pamoate 100 MG [Vistaril] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1484096 | hydroxyzine pamoate 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1484096 | hydroxyzine pamoate 10 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1484143 | Acacia senegal flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484163 | calcium carbonate 34.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1484172 | calcium cabonate 1250 MG per 36.4 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484172 | calcium cabonate 1250 MG per 36.4 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484277 | Trenbolone acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1484277 | Trenbolone acetate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1484277 | Trenbolone acetate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1484278 | Trenbolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484278 | Trenbolone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1484278 | Trenbolone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1484279 | Cucumis sativus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484280 | Zea mays subsp. mays whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484281 | isopropylphthalimide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484283 | sucroferric oxyhydroxide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1484283 | sucroferric oxyhydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484283 | sucroferric oxyhydroxide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1484283 | sucroferric oxyhydroxide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1484283 | sucroferric oxyhydroxide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1484284 | sucroferric oxyhydroxide 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1484285 | sucroferric oxyhydroxide Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1484286 | sucroferric oxyhydroxide Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1484286 | sucroferric oxyhydroxide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1484286 | sucroferric oxyhydroxide Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1484287 | sucroferric oxyhydroxide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1484288 | sucroferric oxyhydroxide Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1484289 | sucroferric oxyhydroxide 500 MG Chewable Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1484289 | sucroferric oxyhydroxide 500 MG Chewable Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1484289 | sucroferric oxyhydroxide 500 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1484289 | sucroferric oxyhydroxide 500 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1484290 | Velphoro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1484291 | sucroferric oxyhydroxide 500 MG [Velphoro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1484292 | sucroferric oxyhydroxide Chewable Tablet [Velphoro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1484293 | Velphoro Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1484294 | Velphoro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1484295 | Velphoro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1484296 | Velphoro 500 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1484296 | Velphoro 500 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1484296 | Velphoro 500 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1484396 | PEG-80 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484399 | Varithena | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1484400 | polidocanol 10 MG/ML [Varithena] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1484402 | Varithena Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1484406 | thymol 0.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1484407 | thymol 0.04 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484407 | thymol 0.04 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484407 | thymol 0.04 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484408 | isopropyl alcohol 650 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1484409 | iodine / isopropyl alcohol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1484410 | iodine / isopropyl alcohol Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1484411 | iodine 7 % / isopropyl alcohol 65 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484411 | iodine 7 % / isopropyl alcohol 65 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484411 | iodine 7 % / isopropyl alcohol 65 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484478 | Iodine tincture | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484487 | capsaicin 0.0083 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1484488 | capsaicin 8.3 MG / menthol 30 MG per 1 GM Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484488 | capsaicin 8.3 MG / menthol 30 MG per 1 GM Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484488 | capsaicin 8.3 MG / menthol 30 MG per 1 GM Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484488 | capsaicin 8.3 MG / menthol 30 MG per 1 GM Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484494 | bilberry seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484495 | decanal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484496 | diisostearoyl polyglyceryl-3 dimer dilinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484497 | farnesal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484498 | ethylhexyl cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484499 | 3-n-butylphthalide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 14845 | apraclonidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 14845 | apraclonidine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 14845 | apraclonidine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 14845 | apraclonidine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 14845 | apraclonidine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1484500 | C11-13 pareth-6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484502 | vanilla planifolia oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484518 | simeprevir sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1484570 | alpha 1-antitrypsin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1484571 | benzyl alcohol / isopropyl alcohol / picrate / tannic acid Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1484731 | D-Cal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1484732 | calcium carbonate 750 MG [D-Cal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484733 | calcium carbonate Chewable Tablet [D-Cal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484734 | D-Cal Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484735 | D-Cal Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484736 | D-Cal Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484737 | D-Cal 750 MG (Ca 300 MG) Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484737 | D-Cal 750 MG (Ca 300 MG) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484737 | D-Cal 750 MG (Ca 300 MG) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484737 | D-Cal 750 MG (Ca 300 MG) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484748 | thymol 0.0005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1484749 | thymol Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1484750 | thymol Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1484751 | thymol 0.05 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484751 | thymol 0.05 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484751 | thymol 0.05 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484752 | novobiocin 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1484753 | penicillin G procaine 20000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1484754 | novobiocin / penicillin G Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1484755 | novobiocin / penicillin G Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1484756 | novobiocin / penicillin G | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1484757 | 10 ML novobiocin 40 MG/ML / penicillin G procaine 20000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484763 | novobiocin 40 MG/ML / penicillin G procaine 20000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484765 | salicyloyl phytosphingosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484766 | salicyloyl phytosphingosine 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1484767 | chlorhexidine / ketoconazole / salicyloyl phytosphingosine Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1484768 | chlorhexidine / ketoconazole / salicyloyl phytosphingosine Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1484769 | chlorhexidine / ketoconazole / salicyloyl phytosphingosine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1484770 | chlorhexidine gluconate 2 % / ketoconazole 1 % / salicyloyl phytosphingosine 0.05 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484770 | chlorhexidine gluconate 2 % / ketoconazole 1 % / salicyloyl phytosphingosine 0.05 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484770 | chlorhexidine gluconate 2 % / ketoconazole 1 % / salicyloyl phytosphingosine 0.05 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484771 | Ketoseb PS | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1484772 | chlorhexidine gluconate 20 MG/ML / ketoconazole 10 MG/ML / salicyloyl phytosphingosine 0.5 MG/ML [Ketoseb PS] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484773 | chlorhexidine / ketoconazole / salicyloyl phytosphingosine Medicated Shampoo [Ketoseb PS] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484774 | Ketoseb PS Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484775 | KETOSEB + PS 2 % / 1 % / 0.05 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484775 | KETOSEB + PS 2 % / 1 % / 0.05 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484775 | KETOSEB + PS 2 % / 1 % / 0.05 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484780 | miconazole / salicylic acid Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1484781 | miconazole / salicylic acid Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1484782 | miconazole / salicylic acid | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1484784 | Dermazole | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1484786 | miconazole / salicylic acid Medicated Shampoo [Dermazole] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484787 | Dermazole Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484789 | Liceall | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1484790 | piperonyl butoxide 30 MG/ML / pyrethrins 3 MG/ML [Liceall] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484791 | piperonyl butoxide / pyrethrins Medicated Shampoo [Liceall] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484792 | Liceall Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484793 | Liceall 3 % / 0.3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484793 | Liceall 3 % / 0.3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484793 | Liceall 3 % / 0.3 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484804 | sodium fluoride 18.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1484805 | sodium fluoride 1.81 % Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1484805 | sodium fluoride 1.81 % Oral Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1484805 | sodium fluoride 1.81 % Oral Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1484806 | sodium fluoride 18.1 MG/ML [Gelato sodium fluoride] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484807 | sodium fluoride Oral Foam [Gelato sodium fluoride] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484808 | Gelato sodium fluoride Oral Foam Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484809 | Gelato 1.81 % Fluoride Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484809 | Gelato 1.81 % Fluoride Oral Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484809 | Gelato 1.81 % Fluoride Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484809 | Gelato 1.81 % Fluoride Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484809 | Gelato 1.81 % Fluoride Oral Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484810 | Gelato Dental Rinse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1484811 | chlorhexidine gluconate 1.2 MG/ML [Gelato Dental Rinse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484812 | chlorhexidine Mouthwash [Gelato Dental Rinse] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484813 | Gelato Dental Rinse Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484814 | Gelato Dental Rinse Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484815 | Gelato Dental Rinse Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484816 | chlorhexidine gluconate 1.2 MG/ML Mouthwash [Gelato Dental Rinse] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484816 | chlorhexidine gluconate 1.2 MG/ML Mouthwash [Gelato Dental Rinse] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484816 | chlorhexidine gluconate 1.2 MG/ML Mouthwash [Gelato Dental Rinse] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484816 | chlorhexidine gluconate 1.2 MG/ML Mouthwash [Gelato Dental Rinse] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484852 | C12-16 pareth-9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484853 | human dander preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484855 | Cannabis sativa subsp. flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484856 | Cicuta virosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484857 | polyacrylic acid (8000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484858 | isopropyl linoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484859 | soy acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484860 | Larrea tridentata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484865 | neral | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484869 | Albadry | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1484870 | novobiocin 40 MG/ML / penicillin G procaine 20000 UNT/ML [Albadry] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484871 | novobiocin / penicillin G Prefilled Syringe [Albadry] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484872 | Albadry Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484873 | 10 ML novobiocin 40 MG/ML / penicillin G procaine 20000 UNT/ML Prefilled Syringe [Albadry] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484873 | 10 ML novobiocin 40 MG/ML / penicillin G procaine 20000 UNT/ML Prefilled Syringe [Albadry] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484873 | 10 ML novobiocin 40 MG/ML / penicillin G procaine 20000 UNT/ML Prefilled Syringe [Albadry] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484874 | novobiocin 40 MG/ML / penicillin G procaine 20000 UNT/ML Prefilled Syringe [Albadry] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484874 | novobiocin 40 MG/ML / penicillin G procaine 20000 UNT/ML Prefilled Syringe [Albadry] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484879 | acetaminophen 500 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1484879 | acetaminophen 500 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1484879 | acetaminophen 500 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1484879 | acetaminophen 500 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1484879 | acetaminophen 500 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1484879 | acetaminophen 500 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1484888 | coal tar / menthol / salicylic acid Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1484889 | coal tar / menthol / salicylic acid Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1484890 | coal tar 2 % / menthol 1 % / salicylic acid 3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484890 | coal tar 2 % / menthol 1 % / salicylic acid 3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484890 | coal tar 2 % / menthol 1 % / salicylic acid 3 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484891 | Pharmasal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1484892 | coal tar 20 MG/ML / menthol 10 MG/ML / salicylic acid 30 MG/ML [Pharmasal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484893 | coal tar / menthol / salicylic acid Medicated Shampoo [Pharmasal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484894 | Pharmasal Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484895 | Pharmasal-T 2 % / 1 % / 3 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484895 | Pharmasal-T 2 % / 1 % / 3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484895 | Pharmasal-T 2 % / 1 % / 3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484902 | Eth estra-Noreth Ac 0.01-1 MG Chewable Tablet (24) / Eth estra 0.01 MG (2) Oral Tablet / Ferr fum 75 MG (2) Oral Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1484902 | Eth estra-Noreth Ac 0.01-1 MG Chewable Tablet (24) / Eth estra 0.01 MG (2) Oral Tablet / Ferr fum 75 MG (2) Oral Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484903 | Lo Minastrin Fe 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1484903 | Lo Minastrin Fe 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484903 | Lo Minastrin Fe 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484904 | saffron extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484911 | sofosbuvir | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1484911 | sofosbuvir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484911 | sofosbuvir | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1484911 | sofosbuvir | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1484911 | sofosbuvir | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1484912 | sofosbuvir 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1484913 | sofosbuvir Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1484913 | sofosbuvir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1484913 | sofosbuvir Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1484914 | sofosbuvir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1484915 | sofosbuvir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1484916 | sofosbuvir 400 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1484916 | sofosbuvir 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1484916 | sofosbuvir 400 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1484916 | sofosbuvir 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1484917 | Sovaldi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1484918 | sofosbuvir 400 MG [Sovaldi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1484919 | sofosbuvir Oral Tablet [Sovaldi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1484922 | Sovaldi 400 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1484922 | Sovaldi 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1484922 | Sovaldi 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1484923 | Sumavel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1484924 | SUMAtriptan 8 MG/ML [Sumavel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484924 | SUMAtriptan 8 MG/ML [Sumavel] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1484926 | Sumavel Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484927 | Sumavel 4 MG in 0.5 ML Jet Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484927 | Sumavel 4 MG in 0.5 ML Jet Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1484927 | Sumavel 4 MG in 0.5 ML Jet Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484927 | Sumavel 4 MG in 0.5 ML Jet Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484927 | Sumavel 4 MG in 0.5 ML Jet Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1484927 | Sumavel 4 MG in 0.5 ML Jet Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484927 | Sumavel 4 MG in 0.5 ML Jet Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484927 | Sumavel 4 MG in 0.5 ML Jet Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484928 | sumatriptan 8 MG/ML Jet Injector [Sumavel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484928 | sumatriptan 8 MG/ML Jet Injector [Sumavel] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1484928 | sumatriptan 8 MG/ML Jet Injector [Sumavel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484928 | sumatriptan 8 MG/ML Jet Injector [Sumavel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484929 | Injectable Foam | Dose Form (DF) | YES | |
| Concept ID (RxCUI): 1484930 | Arkaliox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1484931 | sulbutiamine 200 MG [Arkaliox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1484932 | sulbutiamine Oral Tablet [Arkaliox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484933 | Arkaliox Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484934 | Arkaliox Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1484935 | Arkaliox 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484935 | Arkaliox 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484935 | Arkaliox 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1484937 | common bent pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484937 | common bent pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484937 | common bent pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484938 | Eugenol 85 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484938 | Eugenol 85 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484948 | camphor 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1484948 | camphor 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484948 | camphor 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1484955 | factor IX / factor VII / factor X / protein C / protein S / prothrombin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1484957 | factor IX / factor VII / factor X / protein C / protein S / prothrombin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1484958 | prothrombin complex concentrate (human) 1 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1484958 | prothrombin complex concentrate (human) 1 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1484958 | prothrombin complex concentrate (human) 1 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1484959 | Kcentra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1484962 | Kcentra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1484963 | Kcentra 1 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1484963 | Kcentra 1 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1484963 | Kcentra 1 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1484973 | Alnus glutinosa pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484973 | Alnus glutinosa pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484973 | Alnus glutinosa pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484974 | Alopecurus pratensis pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484974 | Alopecurus pratensis pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484974 | Alopecurus pratensis pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484975 | canola pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484975 | canola pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484975 | canola pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484976 | Bromus commutatus pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484976 | Bromus commutatus pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484977 | common heather pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484977 | common heather pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484977 | common heather pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484978 | Chenopodium bonus-henricus pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484978 | Chenopodium bonus-henricus pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484978 | Chenopodium bonus-henricus pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484979 | Corylus avellana pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1484979 | Corylus avellana pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1484980 | Cynosurus cristatus pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484980 | Cynosurus cristatus pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484981 | common beech pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484981 | common beech pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484981 | common beech pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484982 | common ash pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484982 | common ash pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484982 | common ash pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484982 | common ash pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484983 | greater plantain pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484983 | greater plantain pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484983 | greater plantain pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484984 | Quercus robur pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484984 | Quercus robur pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484984 | Quercus robur pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484985 | Ranunculus bulbosus pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1484985 | Ranunculus bulbosus pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484985 | Ranunculus bulbosus pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484986 | Salix alba pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1484986 | Salix alba pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485 | Beta-keratin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1485 | Beta-keratin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1485045 | hydroxypropyl cellulose (110000 WAMW) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485045 | hydroxypropyl cellulose (110000 WAMW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1485046 | arsenic cation (3+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1485046 | arsenic cation (3+) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485047 | calcium oxalate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1485048 | calcium oxalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485064 | Bambusa bambos whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485065 | Colchicum autumnale seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485066 | Lycopodium clavatum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485067 | polidocanol Injectable Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1485068 | polidocanol 180 MG in 18 ML Injectable Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485068 | polidocanol 180 MG in 18 ML Injectable Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1485068 | polidocanol 180 MG in 18 ML Injectable Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1485068 | polidocanol 180 MG in 18 ML Injectable Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485069 | polidocanol Injectable Foam [Varithena] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1485070 | Varithena 180 MG in 18 ML Injectable Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1485070 | Varithena 180 MG in 18 ML Injectable Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485070 | Varithena 180 MG in 18 ML Injectable Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485070 | Varithena 180 MG in 18 ML Injectable Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1485070 | Varithena 180 MG in 18 ML Injectable Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485071 | Skin TX Medicated Acne Wash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1485072 | salicylic acid 20 MG/ML [Skin TX Medicated Acne Wash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1485073 | salicylic acid Medicated Liquid Soap [Skin TX Medicated Acne Wash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485074 | Skin TX Medicated Acne Wash Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485075 | Skin TX Medicated 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485075 | Skin TX Medicated 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485075 | Skin TX Medicated 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485075 | Skin TX Medicated 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485094 | Vazotab Reformulated Dec 2013 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1485095 | phenylephrine hydrochloride 10 MG / pyrilamine maleate 25 MG [Vazotab Reformulated Dec 2013] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1485096 | phenylephrine / pyrilamine Oral Tablet [Vazotab Reformulated Dec 2013] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485097 | Vazotab Reformulated Dec 2013 Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485098 | Vazotab Reformulated Dec 2013 Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485099 | Vazotab 10 MG / 25 MG Oral Tablet, Reformulated Dec 2013 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485099 | Vazotab 10 MG / 25 MG Oral Tablet, Reformulated Dec 2013 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485099 | Vazotab 10 MG / 25 MG Oral Tablet, Reformulated Dec 2013 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 14851 | Gamma vinyl GABA | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 14851 | Gamma vinyl GABA | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 14851 | Gamma vinyl GABA | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 14851 | Gamma vinyl GABA | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 14851 | Gamma vinyl GABA | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 14851 | Gamma vinyl GABA | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 14851 | Gamma vinyl GABA | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1485119 | PEG-6 sorbitan oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1485120 | Senecio vulgaris extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485121 | butyl acrylate - C16-C20 alkyl methacrylate - methacrylic acid - methyl methacrylate copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485181 | chlorhexidine / ketoconazole Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1485182 | chlorhexidine gluconate 0.3 % / ketoconazole 0.3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485182 | chlorhexidine gluconate 0.3 % / ketoconazole 0.3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485182 | chlorhexidine gluconate 0.3 % / ketoconazole 0.3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1485183 | polyoxyl 30 castor oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1485183 | polyoxyl 30 castor oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485184 | C12-15 pareth-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 14852 | aminomethylbenzoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 14852 | aminomethylbenzoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485210 | benzocaine 10 % / camphor 3 % / phenol 1.35 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485210 | benzocaine 10 % / camphor 3 % / phenol 1.35 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485210 | benzocaine 10 % / camphor 3 % / phenol 1.35 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1485211 | Stingeze Max | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1485212 | benzocaine 100 MG/ML / camphor 30 MG/ML / phenol 13.5 MG/ML [Stingeze Max] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1485213 | benzocaine / camphor / phenol Topical Solution [Stingeze Max] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485214 | Stingeze Max Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485215 | StingEze MAX 10 % / 3 % / 1.35 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485215 | StingEze MAX 10 % / 3 % / 1.35 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485215 | StingEze MAX 10 % / 3 % / 1.35 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485216 | Aloe Vesta Daily Moisturizer | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1485217 | dimethicone 30 MG/ML [Aloe Vesta Daily Moisturizer] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1485218 | dimethicone Topical Lotion [Aloe Vesta Daily Moisturizer] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1485219 | Aloe Vesta Daily Moisturizer Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1485220 | ALOE VESTA Daily Moisturizer 3 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1485220 | ALOE VESTA Daily Moisturizer 3 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485220 | ALOE VESTA Daily Moisturizer 3 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485220 | ALOE VESTA Daily Moisturizer 3 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1485222 | Gentamicin 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485222 | Gentamicin 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1485223 | Orasep Reformulated Dec 2013 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1485224 | benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML [Orasep Reformulated Dec 2013] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1485225 | benzocaine / cetylpyridinium / menthol Mucosal Spray [Orasep Reformulated Dec 2013] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1485226 | Orasep Reformulated Dec 2013 Mucosal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1485227 | Orasep 2 % / 0.5 % / 0.1 % Mucosal Spray, Reformulated Dec 2013 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1485227 | Orasep 2 % / 0.5 % / 0.1 % Mucosal Spray, Reformulated Dec 2013 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485227 | Orasep 2 % / 0.5 % / 0.1 % Mucosal Spray, Reformulated Dec 2013 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1485230 | hypochlorite Irrigation Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1485332 | Vyfemla 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1485332 | Vyfemla 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1485332 | Vyfemla 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485489 | Atopalm Pain Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1485490 | menthol 100 MG/ML / methyl salicylate 150 MG/ML [Atopalm Pain Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1485491 | menthol / methyl salicylate Topical Cream [Atopalm Pain Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485492 | Atopalm Pain Relief Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485493 | ATOPALM Pain Relieving 10 % / 15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485493 | ATOPALM Pain Relieving 10 % / 15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485493 | ATOPALM Pain Relieving 10 % / 15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485493 | ATOPALM Pain Relieving 10 % / 15 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485493 | ATOPALM Pain Relieving 10 % / 15 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485525 | doconexent 265 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1485526 | folic acid 1.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1485531 | alpha tocopherol 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / doconexent 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.2 MG / pyridoxine HCl 25 MG / tricalcium phosphate 160 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1485531 | alpha tocopherol 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / doconexent 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.2 MG / pyridoxine HCl 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485531 | alpha tocopherol 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / doconexent 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.2 MG / pyridoxine HCl 25 MG / tricalcium phosphate 160 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1485531 | alpha tocopherol 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / doconexent 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.2 MG / pyridoxine HCl 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485531 | alpha tocopherol 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / doconexent 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.2 MG / pyridoxine HCl 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485531 | alpha tocopherol 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / doconexent 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.2 MG / pyridoxine HCl 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485531 | alpha tocopherol 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / doconexent 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.2 MG / pyridoxine HCl 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485537 | Periploca sepium root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485538 | Erodium stephanianum top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485539 | lauramidopropyl dimethylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485540 | myristamidopropylamine oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1485541 | C12-20 acid PEG-8 ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485584 | camphor 3 % / menthol 10 % / methyl salicylate 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485584 | camphor 3 % / menthol 10 % / methyl salicylate 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485584 | camphor 3 % / menthol 10 % / methyl salicylate 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1485588 | CTx3 Rinse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1485590 | sodium fluoride Mouthwash [CTx3 Rinse] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485591 | CTx3 Rinse Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485592 | CTx3 Rinse Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485593 | CTx3 Rinse Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485597 | dimethicone 30 MG/ML [Baza Cleanse and Protect] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1485598 | dimethicone 30 MG/ML Medicated Pad [Baza Cleanse and Protect] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485598 | dimethicone 30 MG/ML Medicated Pad [Baza Cleanse and Protect] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485598 | dimethicone 30 MG/ML Medicated Pad [Baza Cleanse and Protect] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485599 | guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1485599 | guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1485599 | guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1485599 | guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1485599 | guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1485606 | Hexi-Dip | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1485607 | chlorhexidine gluconate 10 MG/ML [Hexi-Dip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1485608 | chlorhexidine Topical Solution [Hexi-Dip] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485609 | Hexi-Dip Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485610 | Hexi-Dip 110 1 % Chlorhexidene Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485610 | Hexi-Dip 110 1 % Chlorhexidene Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485610 | Hexi-Dip 110 1 % Chlorhexidene Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485610 | Hexi-Dip 110 1 % Chlorhexidene Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485640 | methyl salicylate Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1485641 | methyl salicylate Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1485642 | methyl salicylate 10 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1485642 | methyl salicylate 10 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485642 | methyl salicylate 10 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485643 | Smartrx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1485644 | methyl salicylate 0.1 MG/MG [Smartrx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1485645 | methyl salicylate Medicated Pad [Smartrx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485646 | Smartrx Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485647 | Smartrx Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1485648 | SMARTRX 10 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1485648 | SMARTRX 10 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485648 | SMARTRX 10 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485648 | SMARTRX 10 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485738 | camphor 56.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1485739 | camphor / capsaicin Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1485740 | camphor / capsaicin Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1485741 | camphor / capsaicin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1485742 | camphor 5.65 % / capsaicin 0.075 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485742 | camphor 5.65 % / capsaicin 0.075 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485742 | camphor 5.65 % / capsaicin 0.075 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1485748 | treprostinil 0.125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1485749 | treprostinil Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1485750 | treprostinil Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1485753 | Orenitram | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1485754 | treprostinil 0.125 MG [Orenitram] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1485756 | Orenitram Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1485757 | Orenitram Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1485759 | treprostinil 0.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1485761 | treprostinil 0.25 MG [Orenitram] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1485763 | treprostinil 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1485765 | treprostinil 1 MG [Orenitram] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1485767 | treprostinil 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1485769 | treprostinil 2.5 MG [Orenitram] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1485785 | apple fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485786 | Mucuna pruriens seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1485787 | p-coumaric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1485787 | p-coumaric acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485796 | Critic-Aid Skin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1485798 | zinc oxide Paste [Critic-Aid Skin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1485799 | Critic-Aid Skin Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1485891 | zinc pyrithione 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1485892 | panthenol / zinc pyrithione Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1485893 | panthenol / zinc pyrithione Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1485894 | panthenol / zinc pyrithione | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1485895 | panthenol 0.5 % / zinc pyrithione 0.6 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1485895 | panthenol 0.5 % / zinc pyrithione 0.6 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1485895 | panthenol 0.5 % / zinc pyrithione 0.6 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486022 | palmitoyllysylvalyldiaminobutyroylthreonine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486023 | hydroxycaprylic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1486024 | hydroxycaprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486025 | flutemetamol (18F) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486025 | flutemetamol (18F) | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1486025 | flutemetamol (18F) | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1486025 | flutemetamol (18F) | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1486025 | flutemetamol (18F) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1486025 | flutemetamol (18F) | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1486026 | flutemetamol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486027 | 2-hydroxycapric acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486027 | 2-hydroxycapric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1486027 | 2-hydroxycapric acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486028 | 2-hydroxydecanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486029 | behenamidopropyl dimethylamine behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486030 | zinc oxide 0.2 MG/MG [Critic-Aid Skin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1486031 | Critic-aid Skin 20 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486031 | Critic-aid Skin 20 % Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486031 | Critic-aid Skin 20 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486031 | Critic-aid Skin 20 % Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486031 | Critic-aid Skin 20 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486086 | Arnica montana flower water | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1486135 | allantoin 11 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486136 | allantoin 1.1 % / dimethicone 1.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486136 | allantoin 1.1 % / dimethicone 1.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486136 | allantoin 1.1 % / dimethicone 1.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486137 | allantoin 1.5 % / dimethicone 1.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486137 | allantoin 1.5 % / dimethicone 1.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486137 | allantoin 1.5 % / dimethicone 1.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486140 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486140 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1486140 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486140 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486140 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1486140 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486140 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1486141 | colloidal oatmeal 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486142 | colloidal oatmeal 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486142 | colloidal oatmeal 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486142 | colloidal oatmeal 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486142 | colloidal oatmeal 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486161 | cysteine hydrochloride 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1486162 | cysteine hydrochloride 50 MG/ML 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486162 | cysteine hydrochloride 50 MG/ML 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486163 | cysteine hydrochloride 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486165 | cysteine HCl 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486165 | cysteine HCl 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486166 | colloidal oatmeal 0.0287 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486167 | colloidal oatmeal 0.00287 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486167 | colloidal oatmeal 0.00287 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486168 | End-Itch | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486169 | colloidal oatmeal 0.0287 MG/ML [End-Itch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486170 | colloidal oatmeal Topical Cream [End-Itch] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486171 | End-Itch Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486172 | End-Itch 0.0287 MG/ML Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486172 | End-Itch 0.0287 MG/ML Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486172 | End-Itch 0.0287 MG/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486173 | cysteine hydrochloride 500 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486174 | cysteine hydrochloride 500 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486177 | hydrocortisone acetate 1.85 % / pramoxine HCl 1.15 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486177 | hydrocortisone acetate 1.85 % / pramoxine HCl 1.15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486177 | hydrocortisone acetate 1.85 % / pramoxine HCl 1.15 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486179 | Iodip | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486180 | iodine 10 MG/ML [Iodip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486181 | iodine Topical Solution [Iodip] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486182 | Iodip Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486183 | IoDip-1000 1 % Iodine Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486183 | IoDip-1000 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486183 | IoDip-1000 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486183 | IoDip-1000 1 % Iodine Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486183 | IoDip-1000 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486183 | IoDip-1000 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486183 | IoDip-1000 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486183 | IoDip-1000 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486185 | iodine 30 MG/ML [Iodip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486186 | iodine 30 MG/ML Topical Solution [Iodip] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486186 | iodine 30 MG/ML Topical Solution [Iodip] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486186 | iodine 30 MG/ML Topical Solution [Iodip] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486186 | iodine 30 MG/ML Topical Solution [Iodip] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486187 | iodine 5 MG/ML [Iodip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486188 | IoDip-510 0.5 % Iodine Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486188 | IoDip-510 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486188 | IoDip-510 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486188 | IoDip-510 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486188 | IoDip-510 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486188 | IoDip-510 0.5 % Iodine Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486188 | IoDip-510 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486190 | minocycline 75 MG [Minocin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486191 | Minocin 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486191 | Minocin 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486191 | Minocin 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486191 | Minocin 75 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486192 | Moderiba | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486193 | ribavirin 400 MG [Moderiba] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486194 | ribavirin Oral Tablet [Moderiba] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486195 | Moderiba Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486196 | Moderiba Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486197 | Moderiba 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486197 | Moderiba 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486197 | Moderiba 400 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486198 | Moderiba 800 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1486198 | Moderiba 800 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486198 | Moderiba 800 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486198 | Moderiba 800 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486199 | ribavirin 200 MG [Moderiba] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486200 | Moderiba 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486200 | Moderiba 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486200 | Moderiba 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486201 | ribavirin 600 MG [Moderiba] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486202 | Moderiba 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486202 | Moderiba 600 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486202 | Moderiba 600 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486203 | Moderiba 1200 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1486203 | Moderiba 1200 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486203 | Moderiba 1200 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486203 | Moderiba 1200 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486245 | vitamin B12 2500 MCG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486245 | vitamin B12 2500 MCG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486245 | vitamin B12 2500 MCG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486245 | vitamin B12 2500 MCG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486248 | chlorpheniramine maleate 4 MG / hydrocodone bitartrate 5 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486248 | chlorpheniramine maleate 4 MG / hydrocodone bitartrate 5 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1486248 | chlorpheniramine maleate 4 MG / hydrocodone bitartrate 5 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486248 | chlorpheniramine maleate 4 MG / hydrocodone bitartrate 5 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1486249 | chlorpheniramine maleate 0.8 MG/ML / hydrocodone bitartrate 1 MG/ML / pseudoephedrine hydrochloride 6 MG/ML [Atuss HS] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486249 | chlorpheniramine maleate 0.8 MG/ML / hydrocodone bitartrate 1 MG/ML / pseudoephedrine hydrochloride 6 MG/ML [Atuss HS] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1486250 | chlorpheniramine / hydrocodone / pseudoephedrine Oral Suspension [Atuss HS] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486250 | chlorpheniramine / hydrocodone / pseudoephedrine Oral Suspension [Atuss HS] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1486251 | chlorpheniramine maleate 0.8 MG/ML / hydrocodone bitartrate 1 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Suspension [Atuss HS] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486251 | chlorpheniramine maleate 0.8 MG/ML / hydrocodone bitartrate 1 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Suspension [Atuss HS] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1486251 | chlorpheniramine maleate 0.8 MG/ML / hydrocodone bitartrate 1 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Suspension [Atuss HS] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486251 | chlorpheniramine maleate 0.8 MG/ML / hydrocodone bitartrate 1 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Suspension [Atuss HS] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1486319 | camphor 0.007 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486320 | levomenthol 0.014 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486321 | methyl salicylate 0.028 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486322 | camphor / levomenthol / methyl salicylate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1486325 | camphor / levomenthol / methyl salicylate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1486326 | camphor 0.7 % / levomenthol 1.4 % / methyl salicylate 2.8 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486326 | camphor 0.7 % / levomenthol 1.4 % / methyl salicylate 2.8 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486326 | camphor 0.7 % / levomenthol 1.4 % / methyl salicylate 2.8 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486337 | sodium fluoride 0.22 MG/ML [Crest] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486338 | Crest 0.022 % (fluoride ion 0.01 % ) Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486338 | Crest 0.022 % (fluoride ion 0.01 % ) Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486338 | Crest 0.022 % (fluoride ion 0.01 % ) Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486338 | Crest 0.022 % (fluoride ion 0.01 % ) Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486338 | Crest 0.022 % (fluoride ion 0.01 % ) Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486338 | Crest 0.022 % (fluoride ion 0.01 % ) Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486338 | Crest 0.022 % (fluoride ion 0.01 % ) Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486338 | Crest 0.022 % (fluoride ion 0.01 % ) Mouthwash | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486349 | cholecalciferol 25 MCG (1000 UNT) Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486349 | cholecalciferol 25 MCG (1000 UNT) Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486349 | cholecalciferol 25 MCG (1000 UNT) Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486391 | Boswellia serrata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1486392 | Morinda officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486396 | Ray Dol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486397 | menthol 100 MG/ML / methyl salicylate 150 MG/ML [Ray Dol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486398 | menthol / methyl salicylate Topical Cream [Ray Dol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486399 | Ray Dol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486400 | Ray Dol (menthol 10 % / methyl salicylate 15 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486400 | Ray Dol (menthol 10 % / methyl salicylate 15 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486400 | Ray Dol (menthol 10 % / methyl salicylate 15 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486411 | coconut oil 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1486412 | coconut oil / linseed oil Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1486413 | coconut oil / linseed oil Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1486414 | coconut oil / linseed oil Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1486415 | coconut oil / linseed oil | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1486416 | coconut oil 500 MG / flaxseed oil 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486416 | coconut oil 500 MG / flaxseed oil 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486416 | coconut oil 500 MG / flaxseed oil 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486436 | dapagliflozin / metFORMIN | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1486436 | dapagliflozin / metFORMIN | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1486452 | WYMZYA Fe 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1486452 | WYMZYA Fe 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486452 | WYMZYA Fe 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486452 | WYMZYA Fe 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486495 | typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Prefilled Syringe [Typhim VI] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486496 | Typhim Vi 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486496 | Typhim Vi 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486496 | Typhim Vi 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486496 | Typhim Vi 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486497 | typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486497 | typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486501 | barium acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486502 | English holly fruiting top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486502 | English holly fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486503 | Sinapis alba allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486503 | Sinapis alba allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486507 | Calophyllum tacamahaca whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486516 | poloxamer 331 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1486517 | Mangifera indica seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486520 | methyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486521 | disodium 2-sulfopalmitate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1486522 | 2-sulfopalmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486523 | disodium carboxyethyl siliconate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1486524 | carboxyethyl siliconate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486526 | CTX4 Rinse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486527 | sodium fluoride 0.5 MG/ML [CTX4 Rinse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486528 | sodium fluoride Mouthwash [CTX4 Rinse] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486529 | CTX4 Rinse Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486530 | CTX4 Rinse Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486531 | CTX4 Rinse Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486532 | CTx4 0.05 % Oral Rinse | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486532 | CTx4 0.05 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486532 | CTx4 0.05 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486532 | CTx4 0.05 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486532 | CTx4 0.05 % Oral Rinse | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486533 | sodium fluoride 0.5 MG/ML [CTx3 Rinse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486534 | CTx3 0.05 % Oral Rinse | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486534 | CTx3 0.05 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486534 | CTx3 0.05 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486534 | CTx3 0.05 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486534 | CTx3 0.05 % Oral Rinse | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486566 | sodium fluoride 1.1 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486566 | sodium fluoride 1.1 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486566 | sodium fluoride 1.1 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486567 | CTX4 Gel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486568 | sodium fluoride 0.011 MG/MG [CTX4 Gel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486569 | sodium fluoride Oral Gel [CTX4 Gel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486570 | CTX4 Gel Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486571 | CTX4 Gel Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486572 | CTx4 Gel 5000 1.1 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486572 | CTx4 Gel 5000 1.1 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486572 | CTx4 Gel 5000 1.1 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486572 | CTx4 Gel 5000 1.1 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486581 | Sovaldi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1486582 | Sovaldi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 14866 | 4-aminoquinoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14866 | 4-aminoquinoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1486663 | glycerin Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1486664 | glycerin Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1486665 | glycerin 2 MG/ML Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486665 | glycerin 2 MG/ML Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486666 | Rovera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486667 | carprofen 100 MG [Rovera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486668 | carprofen Chewable Tablet [Rovera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486669 | Rovera Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486670 | Rovera Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486671 | Rovera Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486672 | Rovera 100 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486672 | Rovera 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486672 | Rovera 100 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486673 | carprofen 25 MG [Rovera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486674 | Rovera 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486674 | Rovera 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486674 | Rovera 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486675 | carprofen 75 MG [Rovera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486676 | Rovera 75 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486676 | Rovera 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486676 | Rovera 75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486677 | black mustard seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486680 | Zetamine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486682 | ketamine Injectable Solution [Zetamine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486683 | Zetamine Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486686 | sapropterin dihydrochloride 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1486687 | sapropterin dihydrochloride 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1486687 | sapropterin dihydrochloride 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486687 | sapropterin dihydrochloride 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1486687 | sapropterin dihydrochloride 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486687 | sapropterin dihydrochloride 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486688 | sapropterin dihydrochloride 100 MG [Kuvan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1486689 | sapropterin Oral Tablet [Kuvan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486690 | Kuvan Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1486691 | KUVAN 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486691 | KUVAN 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486691 | KUVAN 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486692 | selegiline hydrochloride 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486693 | selegiline HCl 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486693 | selegiline HCl 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486694 | selegiline hydrochloride 2 MG [Anipryl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486695 | Anipryl 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486695 | Anipryl 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486695 | Anipryl 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486698 | allantoin 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486699 | allantoin 0.6 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486699 | allantoin 0.6 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486699 | allantoin 0.6 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486701 | allantoin Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1486702 | allantoin 0.5 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486702 | allantoin 0.5 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486702 | allantoin 0.5 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486703 | Theraworx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486704 | allantoin 5 MG/ML [Theraworx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486705 | allantoin Topical Foam [Theraworx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486706 | Theraworx Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486707 | Theraworx 0.5 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486707 | Theraworx 0.5 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486707 | Theraworx 0.5 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486707 | Theraworx 0.5 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486708 | diethylene glycol distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486716 | Opuntia streptacantha stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486717 | polyquaternium-10 (1000 MPA.S at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1486718 | L-erythrulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486759 | kiwi seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1486761 | tolnaftate / triclosan Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1486762 | tolnaftate 1 % / triclosan 0.2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486762 | tolnaftate 1 % / triclosan 0.2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486762 | tolnaftate 1 % / triclosan 0.2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486763 | calcium gluconate 23 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486763 | calcium gluconate 23 % Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486764 | menthol 0.039 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486765 | menthol 3.9 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486765 | menthol 3.9 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486765 | menthol 3.9 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486777 | methanol 140 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486778 | formaldehyde / methanol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1486779 | formaldehyde / methanol Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1486780 | formaldehyde / methanol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1486781 | formaldehyde 37 % / methanol 14 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486781 | formaldehyde 37 % / methanol 14 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486781 | formaldehyde 37 % / methanol 14 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486782 | colloidal oatmeal 1.5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486782 | colloidal oatmeal 1.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486782 | colloidal oatmeal 1.5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486783 | Nail MD Spray | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486784 | tolnaftate 10 MG/ML / triclosan 2 MG/ML [Nail MD Spray] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486785 | tolnaftate / triclosan Topical Spray [Nail MD Spray] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486786 | Nail MD Spray Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486787 | Nail MD 0.2 % / 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486787 | Nail MD 0.2 % / 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486787 | Nail MD 0.2 % / 1 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486788 | Sub Zero | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486789 | menthol 0.039 MG/MG [Sub Zero] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486790 | menthol Topical Gel [Sub Zero] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486791 | Sub Zero Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486792 | sub zero 3.9 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486792 | sub zero 3.9 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486792 | sub zero 3.9 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486792 | sub zero 3.9 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486793 | lowbush blueberry juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486794 | Fragaria ananassa juice | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486794 | Fragaria ananassa juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1486795 | polyglycerin-4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486796 | butyloctyl benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486798 | Androctonus australis venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486799 | gold monoiodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486801 | Lomedia 24 Fe 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1486801 | Lomedia 24 Fe 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486801 | Lomedia 24 Fe 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486818 | 4,5-dichloro-2-octyl-3-isothiazolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486826 | emodepside 19.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486827 | praziquantel 79.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486828 | emodepside 1.98 % / praziquantel 7.94 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486828 | emodepside 1.98 % / praziquantel 7.94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486828 | emodepside 1.98 % / praziquantel 7.94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486828 | emodepside 1.98 % / praziquantel 7.94 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486828 | emodepside 1.98 % / praziquantel 7.94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486828 | emodepside 1.98 % / praziquantel 7.94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486829 | emodepside 19.8 MG/ML / praziquantel 79.4 MG/ML [Profender] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486830 | Profender 1.98 % / 7.94 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486830 | Profender 1.98 % / 7.94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486830 | Profender 1.98 % / 7.94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486830 | Profender 1.98 % / 7.94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486830 | Profender 1.98 % / 7.94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486830 | Profender 1.98 % / 7.94 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486830 | Profender 1.98 % / 7.94 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486836 | ketamine 100 MG/ML [Zetamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486837 | ketamine 100 MG/ML Injectable Solution [Zetamine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486837 | ketamine 100 MG/ML Injectable Solution [Zetamine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486837 | ketamine 100 MG/ML Injectable Solution [Zetamine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486838 | raltegravir 100 MG Granules for Oral Suspension | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1486838 | raltegravir 100 MG Granules for Oral Suspension | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1486838 | raltegravir 100 MG Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486838 | raltegravir 100 MG Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486838 | raltegravir 100 MG Granules for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486841 | Isentress 100 MG Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486841 | Isentress 100 MG Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486841 | Isentress 100 MG Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486841 | Isentress 100 MG Granules for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486842 | Aloe Vesta Antifungal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1486843 | miconazole nitrate 0.02 MG/MG [Aloe Vesta Antifungal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1486844 | miconazole Topical Ointment [Aloe Vesta Antifungal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486845 | Aloe Vesta Antifungal Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1486846 | ALOE VESTA Antifungal 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486846 | ALOE VESTA Antifungal 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486846 | ALOE VESTA Antifungal 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486846 | ALOE VESTA Antifungal 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486846 | ALOE VESTA Antifungal 2 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486874 | menthol 3 % / methyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486874 | menthol 3 % / methyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486874 | menthol 3 % / methyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486875 | Clindamed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486876 | clindamycin 25 MG/ML [Clindamed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486877 | clindamycin Oral Solution [Clindamed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486878 | Clindamed Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486879 | Clindamed Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486880 | clindamycin 25 MG/ML Oral Solution [Clindamed] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486880 | clindamycin 25 MG/ML Oral Solution [Clindamed] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486880 | clindamycin 25 MG/ML Oral Solution [Clindamed] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486881 | Cedrus deodara wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1486892 | Protopam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1486964 | brompheniramine maleate 4 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 7.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486964 | brompheniramine maleate 4 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 7.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486964 | brompheniramine maleate 4 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486966 | dapagliflozin propanediol | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1486966 | dapagliflozin propanediol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1486966 | dapagliflozin propanediol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1486972 | Farxiga | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1486975 | Farxiga Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1486976 | Farxiga Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1486977 | farxiga 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486977 | farxiga 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486977 | farxiga 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486981 | farxiga 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486981 | farxiga 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486981 | farxiga 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486983 | docusate sodium 100 MG per 5 mL Enema | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486983 | docusate sodium 100 MG per 5 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486983 | docusate sodium 100 MG per 5 mL Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1486983 | docusate sodium 100 MG per 5 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486984 | docusate sodium 20 MG/ML [Docusol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1486985 | DocuSol Kids 100 MG per 5 mL Enema | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1486985 | DocuSol Kids 100 MG per 5 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486985 | DocuSol Kids 100 MG per 5 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486985 | DocuSol Kids 100 MG per 5 mL Enema | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1486985 | DocuSol Kids 100 MG per 5 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1486986 | marbofloxacin 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1486987 | marbofloxacin 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486987 | marbofloxacin 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486988 | marbofloxacin 100 MG [Zeniquin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486989 | Zeniquin 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486989 | Zeniquin 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486989 | Zeniquin 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1486990 | glucosamine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1486991 | glucosamine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1486992 | glucosamine sulfate 500 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486992 | glucosamine sulfate 500 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1486993 | Novipet Magic Bites | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1486994 | glucosamine sulfate 500 MG [Novipet Magic Bites] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1486995 | glucosamine Chewable Tablet [Novipet Magic Bites] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486996 | Novipet Magic Bites Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486997 | Novipet Magic Bites Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486998 | Novipet Magic Bites Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1486999 | NoviPet Magic Bites 500 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1486999 | NoviPet Magic Bites 500 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1486999 | NoviPet Magic Bites 500 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487000 | Alocane | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1487005 | oclacitinib maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1487006 | oclacitinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487007 | oclacitinib maleate 16 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487008 | oclacitinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1487009 | oclacitinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1487010 | oclacitinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1487011 | oclacitinib maleate 16 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487011 | oclacitinib maleate 16 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487012 | Apoquel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487013 | oclacitinib maleate 16 MG [Apoquel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487014 | oclacitinib Oral Tablet [Apoquel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487015 | Apoquel Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487016 | Apoquel Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487017 | apoquel 16 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487017 | apoquel 16 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487017 | apoquel 16 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487018 | oclacitinib maleate 3.6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487019 | oclacitinib maleate 3.6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487019 | oclacitinib maleate 3.6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487020 | oclacitinib maleate 3.6 MG [Apoquel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487021 | apoquel 3.6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487021 | apoquel 3.6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487021 | apoquel 3.6 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487022 | oclacitinib maleate 5.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487023 | oclacitinib maleate 5.4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487023 | oclacitinib maleate 5.4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487024 | oclacitinib maleate 5.4 MG [Apoquel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487025 | apoquel 5.4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487025 | apoquel 5.4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487025 | apoquel 5.4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487073 | diclofenac sodium 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1487074 | diclofenac sodium 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487074 | diclofenac sodium 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487074 | diclofenac sodium 2 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1487075 | diclofenac sodium 20 MG/ML [Pennsaid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1487076 | PENNSAID 2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487076 | PENNSAID 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487076 | PENNSAID 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487076 | PENNSAID 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487079 | zinc pyrithione 10 MG/ML [Nioxin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487080 | NIOXIN 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487080 | NIOXIN 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487080 | NIOXIN 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487080 | NIOXIN 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487080 | NIOXIN 1 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487085 | Crambe maritima whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487086 | LARIN 1/20 21 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1487086 | LARIN 1/20 21 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487086 | LARIN 1/20 21 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487087 | lufenuron 230 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487088 | lufenuron / milbemycin oxime / praziquantel Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1487089 | lufenuron / milbemycin oxime / praziquantel Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1487090 | lufenuron / milbemycin oxime / praziquantel Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1487091 | lufenuron / milbemycin oxime / praziquantel Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1487092 | lufenuron / milbemycin oxime / praziquantel | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1487093 | milbemycin oxime 11.5 MG / lufenuron 230 MG / praziquantel 114 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487093 | milbemycin oxime 11.5 MG / lufenuron 230 MG / praziquantel 114 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487094 | Sentinel Spectrum | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487095 | lufenuron 230 MG / milbemycin oxime 11.5 MG / praziquantel 114 MG [Sentinel Spectrum] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487096 | lufenuron / milbemycin oxime / praziquantel Chewable Tablet [Sentinel Spectrum] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487097 | Sentinel Spectrum Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487098 | Sentinel Spectrum Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487099 | Sentinel Spectrum Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487100 | sentinel spectrum 11.5 MG / 230 MG / 114 MG for dogs (25.1-50 lbs.) Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487100 | sentinel spectrum 11.5 MG / 230 MG / 114 MG for dogs (25.1-50 lbs.) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487101 | lufenuron 46 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487102 | praziquantel 22.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487103 | milbemycin oxime 2.3 MG / lufenuron 46 MG / praziquantel 22.8 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487103 | milbemycin oxime 2.3 MG / lufenuron 46 MG / praziquantel 22.8 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487104 | lufenuron 46 MG / milbemycin oxime 2.3 MG / praziquantel 22.8 MG [Sentinel Spectrum] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487105 | sentinel spectrum 2.3 MG / 46 MG / 22.8 MG for dogs 2-8 lbs. Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487105 | sentinel spectrum 2.3 MG / 46 MG / 22.8 MG for dogs 2-8 lbs. Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487106 | lufenuron 460 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487107 | milbemycin oxime 23 MG / lufenuron 460 MG / praziquantel 228 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487107 | milbemycin oxime 23 MG / lufenuron 460 MG / praziquantel 228 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487108 | lufenuron 460 MG / milbemycin oxime 23 MG / praziquantel 228 MG [Sentinel Spectrum] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487109 | sentinel spectrum 23 MG / 460 MG / 228 MG for dogs (50.1-100 lbs.) Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487109 | sentinel spectrum 23 MG / 460 MG / 228 MG for dogs (50.1-100 lbs.) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487110 | lufenuron 115 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487111 | milbemycin oxime 5.75 MG / lufenuron 115 MG / praziquantel 57 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487111 | milbemycin oxime 5.75 MG / lufenuron 115 MG / praziquantel 57 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487112 | lufenuron 115 MG / milbemycin oxime 5.75 MG / praziquantel 57 MG [Sentinel Spectrum] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487113 | sentinel spectrum 5.75 MG / 115 MG / 57 MG for dogs (8.1-25 lbs.) Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487113 | sentinel spectrum 5.75 MG / 115 MG / 57 MG for dogs (8.1-25 lbs.) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487114 | farnesyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1487115 | tridecyl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487116 | benzyl PCA | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487139 | 1,1,2,2-tetrafluoroethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1487140 | Salvia officinalis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487142 | PEG-60 sorbitan stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487143 | sucralfate malate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1487144 | sucralfate malate 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1487148 | Glycerin 40 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487148 | Glycerin 40 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487149 | Dynamiclear Oro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487150 | glycerin 400 MG/ML [Dynamiclear Oro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487151 | glycerin Medicated Pad [Dynamiclear Oro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487152 | Dynamiclear Oro Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487153 | Dynamiclear Oro Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487154 | Dynamiclear ORO 40 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487154 | Dynamiclear ORO 40 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487154 | Dynamiclear ORO 40 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487154 | Dynamiclear ORO 40 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487155 | magnesium phosphate, monobasic, dihydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487156 | sodium lauroyl methyl isethionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1487157 | Bioease Pain Relieving Cold Therapy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487158 | camphor 0.002 MG/MG / menthol 0.035 MG/MG [Bioease Pain Relieving Cold Therapy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487159 | camphor / menthol Topical Gel [Bioease Pain Relieving Cold Therapy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487160 | Bioease Pain Relieving Cold Therapy Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487161 | camphor 0.002 MG/MG / menthol 0.035 MG/MG Topical Gel [Bioease Pain Relieving Cold Therapy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487161 | camphor 0.002 MG/MG / menthol 0.035 MG/MG Topical Gel [Bioease Pain Relieving Cold Therapy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487162 | alpha-bisabolol, (+)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1487164 | isometheptene mucate 130 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487165 | isometheptene mucate 130 MG / caffeine 20 MG / acetaminophen 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487165 | isometheptene mucate 130 MG / caffeine 20 MG / acetaminophen 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487165 | isometheptene mucate 130 MG / caffeine 20 MG / acetaminophen 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487166 | acetaminophen 500 MG / caffeine 20 MG / isometheptene mucate 130 MG [Prodrin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487167 | PRODRIN 130 MG / 20 MG / 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487167 | PRODRIN 130 MG / 20 MG / 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487167 | PRODRIN 130 MG / 20 MG / 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487167 | PRODRIN 130 MG / 20 MG / 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487168 | lufenuron / milbemycin oxime Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1487169 | lufenuron / milbemycin oxime Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1487170 | lufenuron / milbemycin oxime Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1487171 | lufenuron / milbemycin oxime | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1487172 | lufenuron 230 MG / milbemycin oxime 11.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487172 | lufenuron 230 MG / milbemycin oxime 11.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487173 | Sentinel Flavor Tabs | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487174 | lufenuron 230 MG / milbemycin oxime 11.5 MG [Sentinel Flavor Tabs] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487175 | lufenuron / milbemycin oxime Oral Tablet [Sentinel Flavor Tabs] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487176 | Sentinel Flavor Tabs Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487177 | Sentinel Flavor Tabs Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487178 | sentinel flavor tabs 11.5 MG / 230 MG for dogs (26-50 lbs.) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487178 | sentinel flavor tabs 11.5 MG / 230 MG for dogs (26-50 lbs.) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487178 | sentinel flavor tabs 11.5 MG / 230 MG for dogs (26-50 lbs.) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487179 | lufenuron 46 MG / milbemycin oxime 2.3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487179 | lufenuron 46 MG / milbemycin oxime 2.3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487180 | lufenuron 46 MG / milbemycin oxime 2.3 MG [Sentinel Flavor Tabs] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487181 | sentinel flavor tabs 2.3 MG / 46 MG for dogs (2-10 lbs.) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487181 | sentinel flavor tabs 2.3 MG / 46 MG for dogs (2-10 lbs.) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487181 | sentinel flavor tabs 2.3 MG / 46 MG for dogs (2-10 lbs.) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487182 | lufenuron 460 MG / milbemycin oxime 23 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487182 | lufenuron 460 MG / milbemycin oxime 23 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487183 | lufenuron 460 MG / milbemycin oxime 23 MG [Sentinel Flavor Tabs] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487184 | sentinel flavor tabs 23 MG / 460 MG for dogs (51-100 lbs.) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487184 | sentinel flavor tabs 23 MG / 460 MG for dogs (51-100 lbs.) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487184 | sentinel flavor tabs 23 MG / 460 MG for dogs (51-100 lbs.) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487185 | lufenuron 115 MG / milbemycin oxime 5.75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487185 | lufenuron 115 MG / milbemycin oxime 5.75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487186 | lufenuron 115 MG / milbemycin oxime 5.75 MG [Sentinel Flavor Tabs] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487187 | sentinel flavor tabs 5.75 MG / 115 MG for dogs (11-25 lbs.) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487187 | sentinel flavor tabs 5.75 MG / 115 MG for dogs (11-25 lbs.) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487187 | sentinel flavor tabs 5.75 MG / 115 MG for dogs (11-25 lbs.) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487188 | benzyl acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1487189 | lanosteryl stearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1487195 | danofloxacin 180 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487196 | danofloxacin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1487197 | danofloxacin Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1487198 | danofloxacin 180 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487199 | Advocin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487200 | danofloxacin 180 MG/ML [Advocin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487201 | danofloxacin Injectable Solution [Advocin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487202 | Advocin Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487203 | Advocin 180 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487203 | Advocin 180 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487203 | Advocin 180 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487203 | Advocin 180 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487208 | petrolatum 0.895 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487209 | petrolatum 89.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487209 | petrolatum 89.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487209 | petrolatum 89.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487215 | sucralfate Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1487216 | sucralfate Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1487217 | sucralfate Oral Paste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1487218 | sucralfate malate 10 % Mucus Membrane Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487218 | sucralfate malate 10 % Mucus Membrane Oral Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487218 | sucralfate malate 10 % Mucus Membrane Oral Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1487250 | acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG [Zebutal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1487251 | ZEBUTAL 50 MG / 325 MG / 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487251 | ZEBUTAL 50 MG / 325 MG / 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487251 | ZEBUTAL 50 MG / 325 MG / 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487251 | ZEBUTAL 50 MG / 325 MG / 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487266 | sodium fluoride 20 MG/ML [Gelato sodium fluoride] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487267 | Gelato 2 % Oral Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487267 | Gelato 2 % Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487267 | Gelato 2 % Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487267 | Gelato 2 % Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487267 | Gelato 2 % Oral Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487268 | calcium glycerophosphate 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487269 | calcium lactate 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487270 | calcium glycerophosphate / calcium lactate Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1487271 | calcium glycerophosphate / calcium lactate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1487274 | Vetribute | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487275 | phenylbutazone 1000 MG [Vetribute] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487276 | phenylbutazone Oral Tablet [Vetribute] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487277 | Vetribute Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487278 | Vetribute Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487279 | VetriBute Bolus 1 GM Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487279 | VetriBute Bolus 1 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487279 | VetriBute Bolus 1 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487279 | VetriBute Bolus 1 GM Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487280 | Paradyne | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487281 | selamectin 120 MG/ML [Paradyne] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487282 | selamectin Topical Solution [Paradyne] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487283 | Paradyne Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487284 | Paradyne 120 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487284 | Paradyne 120 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487284 | Paradyne 120 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487285 | selamectin 60 MG/ML [Paradyne] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487286 | Paradyne 60 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487286 | Paradyne 60 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487286 | Paradyne 60 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487287 | acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG [Endocet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1487287 | acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG [Endocet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1487288 | ENDOCET 2.5 MG / 325 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487288 | ENDOCET 2.5 MG / 325 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1487288 | ENDOCET 2.5 MG / 325 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487288 | ENDOCET 2.5 MG / 325 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1487288 | ENDOCET 2.5 MG / 325 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487288 | ENDOCET 2.5 MG / 325 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1487288 | ENDOCET 2.5 MG / 325 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487295 | calcium glycerophosphate / calcium lactate Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1487296 | calcium glycerophosphate 50 MG/ML / calcium lactate 50 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487356 | gonadorelin 0.05 MG/ML [Factrel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487357 | gonadorelin 0.05 MG/ML Injectable Solution [Factrel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487357 | gonadorelin 0.05 MG/ML Injectable Solution [Factrel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487357 | gonadorelin 0.05 MG/ML Injectable Solution [Factrel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487357 | gonadorelin 0.05 MG/ML Injectable Solution [Factrel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487360 | glatiramer acetate 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1487361 | glatiramer acetate 40 MG/ML in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1487361 | glatiramer acetate 40 MG/ML in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487361 | glatiramer acetate 40 MG/ML in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487362 | glatiramer acetate 40 MG/ML [Copaxone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1487363 | Copaxone 40 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487363 | Copaxone 40 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487363 | Copaxone 40 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487363 | Copaxone 40 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487364 | glatiramer acetate 40 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487365 | glatiramer acetate 40 MG/ML Prefilled Syringe [Copaxone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487365 | glatiramer acetate 40 MG/ML Prefilled Syringe [Copaxone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487366 | desvenlafaxine fumarate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1487367 | hydroxyethyl cellulose (280 MPA.S at 5%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1487368 | dextromethorphan hydrobromide 7.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1487369 | dextromethorphan HBr 7.5 MG / guaiFENesin 88 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487369 | dextromethorphan HBr 7.5 MG / guaiFENesin 88 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487369 | dextromethorphan HBr 7.5 MG / guaiFENesin 88 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1487369 | dextromethorphan HBr 7.5 MG / guaiFENesin 88 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1487369 | dextromethorphan HBr 7.5 MG / guaiFENesin 88 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1487370 | salicylic acid 285 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1487371 | salicylic acid 28.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487371 | salicylic acid 28.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487371 | salicylic acid 28.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1487372 | Ultrasal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1487373 | salicylic acid 285 MG/ML [Ultrasal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1487374 | salicylic acid Topical Solution [Ultrasal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487375 | Ultrasal Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1487376 | UltraSal-ER 28.5 % Wart Remover Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487376 | UltraSal-ER 28.5 % Wart Remover Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487376 | UltraSal-ER 28.5 % Wart Remover Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487376 | UltraSal-ER 28.5 % Wart Remover Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487424 | Red Lion Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487425 | menthol 30 MG/ML [Red Lion Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487426 | menthol Topical Cream [Red Lion Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487427 | Red Lion Relief Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487428 | Red Lion Relief 30 MG/ML Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487428 | Red Lion Relief 30 MG/ML Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487428 | Red Lion Relief 30 MG/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487488 | Atrax robustus antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487488 | Atrax robustus antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1487488 | Atrax robustus antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1487489 | Latrodectus hasselti antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487489 | Latrodectus hasselti antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1487489 | Latrodectus hasselti antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1487494 | Viral surface antigen protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1487494 | Viral surface antigen protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1487498 | Moderiba 600 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1487498 | Moderiba 600 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487498 | Moderiba 600 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487498 | Moderiba 600 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487500 | Moderiba 1000 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1487500 | Moderiba 1000 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487500 | Moderiba 1000 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487500 | Moderiba 1000 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487505 | Geranium maculatum root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1487507 | Prunus armeniaca leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487511 | behenyl benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487512 | Umeclidinium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1487512 | Umeclidinium bromide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1487512 | Umeclidinium bromide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1487514 | umeclidinium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1487514 | umeclidinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1487514 | umeclidinium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1487514 | umeclidinium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1487514 | umeclidinium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1487515 | umeclidinium 0.0625 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1487516 | umeclidinium / vilanterol Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1487517 | umeclidinium / vilanterol Dry Powder Inhaler | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1487518 | umeclidinium / vilanterol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1487519 | umeclidinium/vilanterol 62.5/25 MCG/INHAL Dry Powder Inhaler, 7 Blisters | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1487519 | umeclidinium/vilanterol 62.5/25 MCG/INHAL Dry Powder Inhaler, 7 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487519 | umeclidinium/vilanterol 62.5/25 MCG/INHAL Dry Powder Inhaler, 7 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487520 | Anoro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1487521 | umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT [Anoro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1487522 | umeclidinium / vilanterol Dry Powder Inhaler [Anoro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487523 | Anoro Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1487524 | ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 7 Blisters | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487524 | ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 7 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487524 | ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 7 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487525 | umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487525 | umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487526 | umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Anoro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487526 | umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Anoro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487527 | umeclidinium/vilanterol 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1487527 | umeclidinium/vilanterol 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487527 | umeclidinium/vilanterol 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487528 | ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487528 | ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487528 | ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487529 | cetyl behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487530 | hexasodium hexametaphosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1487531 | hexametaphosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487532 | lecithin, sunflower | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487532 | lecithin, sunflower | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1487533 | sodium tripolyphosphate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1487534 | triphosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487606 | salicylic acid 176 MG/ML [Freezone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1487607 | Freezone 17.6 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487607 | Freezone 17.6 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487607 | Freezone 17.6 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487607 | Freezone 17.6 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487609 | fentaNYL 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487609 | fentaNYL 50 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1487610 | fentaNYL Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1487610 | fentaNYL Topical Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1487611 | fentaNYL 50 MG/ML Transdermal Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487611 | fentaNYL 50 MG/ML Transdermal Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1487611 | fentaNYL 50 MG/ML Transdermal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487612 | Recuvyra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487613 | fentaNYL 50 MG/ML [Recuvyra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487613 | fentaNYL 50 MG/ML [Recuvyra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1487614 | fentaNYL Topical Solution [Recuvyra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487614 | fentaNYL Topical Solution [Recuvyra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1487615 | Recuvyra Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487616 | Recuvyra 50 MG/ML Transdermal Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487616 | Recuvyra 50 MG/ML Transdermal Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1487616 | Recuvyra 50 MG/ML Transdermal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487616 | Recuvyra 50 MG/ML Transdermal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487623 | Berberex Wound Cleanser | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487624 | allantoin 5 MG/ML / benzethonium chloride 1 MG/ML [Berberex Wound Cleanser] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487625 | allantoin / benzethonium Topical Solution [Berberex Wound Cleanser] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487626 | Berberex Wound Cleanser Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487627 | BerbereX Wound Cleanser 0.5 % / 0.1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487627 | BerbereX Wound Cleanser 0.5 % / 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487627 | BerbereX Wound Cleanser 0.5 % / 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487627 | BerbereX Wound Cleanser 0.5 % / 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487763 | camphor 0.5 % / menthol 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487763 | camphor 0.5 % / menthol 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487763 | camphor 0.5 % / menthol 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487764 | doxylamine succinate 1.95 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487765 | doxylamine succinate 9.75 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487765 | doxylamine succinate 9.75 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487765 | doxylamine succinate 9.75 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487768 | lidocaine hydrochloride 25 MG/ML [Unburn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487769 | lidocaine Topical Spray [Unburn] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487770 | unburn SUNBURN RELIEF 2.5 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487770 | unburn SUNBURN RELIEF 2.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487770 | unburn SUNBURN RELIEF 2.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487770 | unburn SUNBURN RELIEF 2.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487826 | 1-octanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1487827 | Canarium luzonicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487829 | Cinnamomum camphora whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487830 | Geranium maculatum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487831 | Hyoscyamus niger leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487832 | Melaleuca alternifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487833 | cowslip flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487833 | cowslip flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487834 | Pogostemon cablin whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487835 | butyl levulinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487902 | Dr. J.I.s Arthritis Plus Gel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1487903 | camphor 0.03 MG/MG / menthol 0.12 MG/MG / methyl salicylate 0.15 MG/MG [Dr. J.I.s Arthritis Plus Gel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1487904 | camphor / menthol / methyl salicylate Topical Gel [Dr. J.I.s Arthritis Plus Gel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487905 | Dr. J.I.s Arthritis Plus Gel Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1487906 | Dr. J.I.s ARTHRITIS PLUS 3 % / 12 % / 15 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1487906 | Dr. J.I.s ARTHRITIS PLUS 3 % / 12 % / 15 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487906 | Dr. J.I.s ARTHRITIS PLUS 3 % / 12 % / 15 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487907 | dinitolmide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487908 | camphor 4.8 % / menthol 1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487908 | camphor 4.8 % / menthol 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487908 | camphor 4.8 % / menthol 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1487909 | Eperua falcata bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1487911 | posaconazole 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1487912 | posaconazole 200 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1487912 | posaconazole 200 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1487921 | Nikzon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1487922 | phenylephrine hydrochloride 2.5 MG/ML / pramoxine hydrochloride 10 MG/ML [Nikzon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1487923 | phenylephrine / pramoxine Rectal Cream [Nikzon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487924 | Nikzon Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1487925 | Nikzon 0.25 % / 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1487925 | Nikzon 0.25 % / 1 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1487925 | Nikzon 0.25 % / 1 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1487926 | sodium beta-sitosteryl sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1487927 | beta-sitosteryl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1488038 | Orastat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1488039 | benzocaine 0.2 MG/MG [Orastat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1488040 | benzocaine Oral Gel [Orastat] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488041 | Orastat Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488042 | Orastat Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488043 | Orastat 20 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488043 | Orastat 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488043 | Orastat 20 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488043 | Orastat 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488044 | tretinoin 0.0008 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1488045 | tretinoin 0.08 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1488045 | tretinoin 0.08 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488045 | tretinoin 0.08 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488046 | tretinoin 0.0008 MG/MG [Retin-A] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1488047 | RETIN-A MICRO 0.08 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488047 | RETIN-A MICRO 0.08 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488047 | RETIN-A MICRO 0.08 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488047 | RETIN-A MICRO 0.08 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488047 | RETIN-A MICRO 0.08 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1488054 | cetyl hydroxyethylcellulose (550000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1488055 | diheptyl succinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1488062 | Pegylax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1488066 | Pegylax Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488067 | PEGyLAX 17 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488067 | PEGyLAX 17 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488067 | PEGyLAX 17 GM Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488068 | ProDenRx Rinse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1488069 | sodium fluoride 2 MG/ML [ProDenRx Rinse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1488070 | sodium fluoride Mouthwash [ProDenRx Rinse] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1488071 | ProDenRx Rinse Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1488072 | ProDenRx Rinse Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1488073 | ProDenRx Rinse Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1488074 | Pro-Den Rx 0.2 % (fluoride ion 0.9 % ) Oral Rinse | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488074 | Pro-Den Rx 0.2 % (fluoride ion 0.9 % ) Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488074 | Pro-Den Rx 0.2 % (fluoride ion 0.9 % ) Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488074 | Pro-Den Rx 0.2 % (fluoride ion 0.9 % ) Oral Rinse | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1488097 | methyl salicylate 60 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488097 | methyl salicylate 60 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488097 | methyl salicylate 60 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488215 | diphenhydramine hydrochloride 1.67 MG/ML [Unisom Sleep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1488215 | diphenhydramine hydrochloride 1.67 MG/ML [Unisom Sleep] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1488216 | diphenhydrAMINE Oral Solution [Unisom Sleep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488216 | diphenhydrAMINE Oral Solution [Unisom Sleep] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1488217 | Unisom Sleep Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488218 | diphenhydramine hydrochloride 1.67 MG/ML Oral Solution [Unisom Sleep] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488218 | diphenhydramine hydrochloride 1.67 MG/ML Oral Solution [Unisom Sleep] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1488218 | diphenhydramine hydrochloride 1.67 MG/ML Oral Solution [Unisom Sleep] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488218 | diphenhydramine hydrochloride 1.67 MG/ML Oral Solution [Unisom Sleep] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1488218 | diphenhydramine hydrochloride 1.67 MG/ML Oral Solution [Unisom Sleep] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488225 | Sus scrofa fallopian tube preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1488226 | Galium boreale leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1488227 | Equus caballus leg callous preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1488263 | Vernicia fordii seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1488267 | moxidectin / praziquantel Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1488269 | moxidectin / praziquantel | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1488293 | Recombinant coagulation factor XIIIa | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1488293 | Recombinant coagulation factor XIIIa | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1488293 | Recombinant coagulation factor XIIIa | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1488293 | Recombinant coagulation factor XIIIa | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1488293 | Recombinant coagulation factor XIIIa | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1488293 | Recombinant coagulation factor XIIIa | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488296 | Tretten | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1488299 | Tretten Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1488302 | coagulation factor XIII a-subunit (recombinant) 1 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488302 | coagulation factor XIII a-subunit (recombinant) 1 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1488304 | Tretten 1 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1488304 | Tretten 1 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488304 | Tretten 1 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488306 | menthol 6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488306 | menthol 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488306 | menthol 6 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488308 | Quest Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1488312 | Quest Plus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488326 | benzyl alcohol 0.19 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488327 | benzyl alcohol / lidocaine Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1488328 | benzyl alcohol 19 % / lidocaine HCl 4 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488328 | benzyl alcohol 19 % / lidocaine HCl 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488328 | benzyl alcohol 19 % / lidocaine HCl 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488329 | Biochemistry Heel No Pain | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1488330 | benzyl alcohol 0.19 ML/ML / lidocaine hydrochloride 40 MG/ML [Biochemistry Heel No Pain] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1488331 | benzyl alcohol / lidocaine Topical Spray [Biochemistry Heel No Pain] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488332 | Biochemistry Heel No Pain Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488333 | biochemistry Heel No Pain 19 % / 4 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488333 | biochemistry Heel No Pain 19 % / 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488333 | biochemistry Heel No Pain 19 % / 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488353 | DECARA 1.25 MG (50,000 UNT) Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1488353 | DECARA 1.25 MG (50,000 UNT) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488353 | DECARA 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488353 | DECARA 1.25 MG (50,000 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488359 | praziquantel 0.125 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488360 | moxidectin / praziquantel Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1488361 | moxidectin / praziquantel Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1488362 | moxidectin 2 % / praziquantel 12.5 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488362 | moxidectin 2 % / praziquantel 12.5 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488362 | moxidectin 2 % / praziquantel 12.5 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488363 | moxidectin 0.02 MG/MG / praziquantel 0.125 MG/MG [Quest Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1488364 | moxidectin / praziquantel Oral Gel [Quest Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488365 | Quest Plus Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488366 | QUEST PLUS 2 % / 12.5 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488366 | QUEST PLUS 2 % / 12.5 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488366 | QUEST PLUS 2 % / 12.5 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488368 | technetium Tc-99m pyrophosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1488375 | factor VIII / von Willebrand factor Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1488376 | factor VIII / von Willebrand factor Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1488408 | factor VIII, human 33.3 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488409 | von Willebrand factor, human 66.7 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488414 | factor VIII, human 25 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488415 | von Willebrand factor, human 50 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488523 | doramectin 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488524 | doramectin Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1488525 | doramectin Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1488526 | doramectin 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488526 | doramectin 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488526 | doramectin 0.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488527 | doramectin 5 MG/ML [Dectomax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1488528 | doramectin Topical Solution [Dectomax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488529 | Dectomax Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488530 | DECTOMAX Pour-On for Cattle 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488530 | DECTOMAX Pour-On for Cattle 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488530 | DECTOMAX Pour-On for Cattle 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488530 | DECTOMAX Pour-On for Cattle 0.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488532 | Furoquid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1488533 | furosemide 10 MG/ML [Furoquid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1488534 | furosemide Oral Solution [Furoquid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488535 | Furoquid Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488536 | Furoquid Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488537 | furosemide 10 MG/ML Oral Solution [Furoquid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488537 | furosemide 10 MG/ML Oral Solution [Furoquid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488537 | furosemide 10 MG/ML Oral Solution [Furoquid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488543 | Eucalyptus oil 0.11 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488544 | methyl salicylate 0.22 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488545 | camphor 2 % / eucalyptus oil 11 % / menthol 11 % / methyl salicylate 22 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488545 | camphor 2 % / eucalyptus oil 11 % / menthol 11 % / methyl salicylate 22 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488545 | camphor 2 % / eucalyptus oil 11 % / menthol 11 % / methyl salicylate 22 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488554 | lycopene 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488555 | lycopene 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488555 | lycopene 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488563 | cyanocobalamin 3000 MCG/mL Sublingual Drops | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488563 | cyanocobalamin 3000 MCG/mL Sublingual Drops | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488563 | cyanocobalamin 3000 MCG/mL Sublingual Drops | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1488564 | dapagliflozin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1488564 | dapagliflozin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1488564 | dapagliflozin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1488564 | dapagliflozin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1488564 | dapagliflozin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1488565 | dapagliflozin 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1488566 | dapagliflozin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1488566 | dapagliflozin Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1488566 | dapagliflozin Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1488567 | dapagliflozin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1488568 | dapagliflozin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1488569 | dapagliflozin 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1488569 | dapagliflozin 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488569 | dapagliflozin 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488569 | dapagliflozin 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1488569 | dapagliflozin 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1488573 | dapagliflozin 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1488574 | dapagliflozin 5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1488574 | dapagliflozin 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488574 | dapagliflozin 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488574 | dapagliflozin 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1488574 | dapagliflozin 5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1488575 | biotin / panthenol Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1488576 | biotin / panthenol Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1488577 | biotin / panthenol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1488578 | biotin 0.06 % / panthenol 0.2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488578 | biotin 0.06 % / panthenol 0.2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488578 | biotin 0.06 % / panthenol 0.2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488588 | pyrithione zinc 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488588 | pyrithione zinc 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488588 | pyrithione zinc 0.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488597 | Medibac Clearing Complex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1488598 | salicylic acid 5 MG/ML [Medibac Clearing Complex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1488599 | salicylic acid Topical Solution [Medibac Clearing Complex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488601 | Medibac Clearing Complex Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488602 | MediBac clearing complex acne treatment 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488602 | MediBac clearing complex acne treatment 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488602 | MediBac clearing complex acne treatment 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488602 | MediBac clearing complex acne treatment 0.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488616 | leuprolide Ac 11.25 MG in 1.5 ML (1) Prefilled Syringe / noreth Ac 5 MG (90) Oral Tablet 3 Month Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1488616 | leuprolide Ac 11.25 MG in 1.5 ML (1) Prefilled Syringe / noreth Ac 5 MG (90) Oral Tablet 3 Month Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488616 | leuprolide Ac 11.25 MG in 1.5 ML (1) Prefilled Syringe / noreth Ac 5 MG (90) Oral Tablet 3 Month Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488617 | Lupaneta Pack 11.25 MG 3-Month | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1488617 | Lupaneta Pack 11.25 MG 3-Month | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488617 | Lupaneta Pack 11.25 MG 3-Month | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488618 | leuprolide Ac 3.75 MG in 1 ML (1) Prefilled Syringe / noreth Ac 5 MG (30) Oral Tablet 1 Month Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1488618 | leuprolide Ac 3.75 MG in 1 ML (1) Prefilled Syringe / noreth Ac 5 MG (30) Oral Tablet 1 Month Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488618 | leuprolide Ac 3.75 MG in 1 ML (1) Prefilled Syringe / noreth Ac 5 MG (30) Oral Tablet 1 Month Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488619 | Lupaneta Pack 3.75 MG 1-Month | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1488619 | Lupaneta Pack 3.75 MG 1-Month | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1488619 | Lupaneta Pack 3.75 MG 1-Month | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1488624 | sodium bicarbonate 2.6 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488624 | sodium bicarbonate 2.6 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1488624 | sodium bicarbonate 2.6 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488624 | sodium bicarbonate 2.6 GM Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488632 | buprenorphine hydrochloride 1.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1488633 | buprenorphine Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1488634 | buprenorphine hydrochloride 1.3 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1488635 | Animalgesics | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1488636 | buprenorphine hydrochloride 1.3 MG/ML [Animalgesics] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1488637 | buprenorphine Injectable Suspension [Animalgesics] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488638 | Animalgesics Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1488639 | buprenorphine hydrochloride 1.3 MG/ML Injectable Suspension [Animalgesics] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488639 | buprenorphine hydrochloride 1.3 MG/ML Injectable Suspension [Animalgesics] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1488644 | Diclofenac specific immunoglobulin E | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1488644 | Diclofenac specific immunoglobulin E | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1488645 | Rose pollen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1488645 | Rose pollen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1488645 | Rose pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488651 | Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1488652 | Gadoterate immunoglobulin E | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1488652 | Gadoterate immunoglobulin E | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1488655 | Bamboo wood | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1488655 | Bamboo wood | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1488655 | Bamboo wood | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1488663 | Gadopentetate immunoglobulin E | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1488663 | Gadopentetate immunoglobulin E | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1488664 | treprostinil Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |